# EDGAR Filing Document

**Accession Number:** 0001670541
**File Stem:** 0001670541-26-000060
**Filing Date:** 2026-5
**Character Count:** 199381
**Document Hash:** 225e66bb1ed78b0e529e56ba9b961968
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001670541-26-000060.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001670541-26-000060

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 95

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Adient plc
- **CENTRAL INDEX KEY:** 0001670541
- **STANDARD INDUSTRIAL CLASSIFICATION:** MOTOR VEHICLE PARTS & ACCESSORIES [3714]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37757
- **FILM NUMBER:** 26948681

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 25 NORTH WALL QUAY
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2
- **BUSINESS PHONE:** 1-734-254-5000

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 25 NORTH WALL QUAY
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Adient Ltd
- **DATE OF NAME CHANGE:** 20160328

?xml version='1.0' encoding='ASCII'? adnt-20260331

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

---

| | |
|:---|:---|
| **FORM** | **10-Q** |

---

☑ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the quarterly period ended March 31, 2026

or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from __________ to __________

Commission File Number: 001-37757

---

| | |
|:---|:---|
| | ![ADNT.jpg](adnt-20260331_g1.jpg) |
| **Adient plc** | **Adient plc** |
| (exact name of Registrant as specified in its charter) | (exact name of Registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Ireland** | **98-1328821** |
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer - Identification No.) |
| **25 North Wall Quay, Dublin 1, Ireland D01 H104** | **25 North Wall Quay, Dublin 1, Ireland D01 H104** |
| (Address of principal executive offices) | (Address of principal executive offices) |
| **734-254-5000** | **734-254-5000** |
| (Registrant's telephone number, including area code) | (Registrant's telephone number, including area code) |

---

---

| | | |
|:---|:---|:---|
| Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: | Securities registered pursuant to Section 12(b) of the Act: |
| **<u>Title of each class</u>** | **<u>Trading symbol</u>** | **<u>Name of exchange on which registered</u>** |
| Ordinary Shares, par value $0.001 | ADNT | New York Stock Exchange |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☑ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). &nbsp;&nbsp;&nbsp;&nbsp;Yes ☐ No ☑

At March 31, 2026, 78,413,387 ordinary shares were outstanding.

------

**Adient plc**

**Form 10-Q**

**For the Three Months Ended March 31, 2026** 

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| <u>[PART I - FINANCIAL INFORMATION](#i6a68ddbec169429884f34b7f5111d27e_10)</u> | <u>[PART I - FINANCIAL INFORMATION](#i6a68ddbec169429884f34b7f5111d27e_10)</u> | <u>[PART I - FINANCIAL INFORMATION](#i6a68ddbec169429884f34b7f5111d27e_10)</u> |
| <u>[Item 1.](#i6a68ddbec169429884f34b7f5111d27e_13)</u> | <u>[Unaudited Financial Statements](#i6a68ddbec169429884f34b7f5111d27e_13)</u> | <u>[3](#i6a68ddbec169429884f34b7f5111d27e_13)</u> |
| <u>[Item 2.](#i6a68ddbec169429884f34b7f5111d27e_85)</u> | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#i6a68ddbec169429884f34b7f5111d27e_85)</u> | <u>[35](#i6a68ddbec169429884f34b7f5111d27e_85)</u> |
| <u>[Item 3.](#i6a68ddbec169429884f34b7f5111d27e_109)</u> | <u>[Quantitative and Qualitative Disclosures About Market Risk](#i6a68ddbec169429884f34b7f5111d27e_109)</u> | <u>[48](#i6a68ddbec169429884f34b7f5111d27e_109)</u> |
| <u>[Item 4.](#i6a68ddbec169429884f34b7f5111d27e_112)</u> | <u>[Controls and Procedures](#i6a68ddbec169429884f34b7f5111d27e_112)</u> | <u>[48](#i6a68ddbec169429884f34b7f5111d27e_112)</u> |
| <u>[PART II - OTHER INFORMATION](#i6a68ddbec169429884f34b7f5111d27e_115)</u> | <u>[PART II - OTHER INFORMATION](#i6a68ddbec169429884f34b7f5111d27e_115)</u> | <u>[PART II - OTHER INFORMATION](#i6a68ddbec169429884f34b7f5111d27e_115)</u> |
| <u>[Item 1.](#i6a68ddbec169429884f34b7f5111d27e_118)</u>  | <u>[Legal Proceedings](#i6a68ddbec169429884f34b7f5111d27e_118)</u> | <u>[49](#i6a68ddbec169429884f34b7f5111d27e_118)</u> |
| <u>[Item 1A.](#i6a68ddbec169429884f34b7f5111d27e_121)</u> | <u>[Risk Factors](#i6a68ddbec169429884f34b7f5111d27e_121)</u> | <u>[49](#i6a68ddbec169429884f34b7f5111d27e_121)</u> |
| <u>[Item 2.](#i6a68ddbec169429884f34b7f5111d27e_124)</u> | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#i6a68ddbec169429884f34b7f5111d27e_124)</u> | <u>[50](#i6a68ddbec169429884f34b7f5111d27e_124)</u> |
| <u>[Item 3.](#i6a68ddbec169429884f34b7f5111d27e_127)</u> | <u>[Defaults Upon Senior Securities](#i6a68ddbec169429884f34b7f5111d27e_127)</u> | <u>[50](#i6a68ddbec169429884f34b7f5111d27e_127)</u> |
| <u>[Item 4.](#i6a68ddbec169429884f34b7f5111d27e_130)</u> | <u>[Mine Safety Disclosures](#i6a68ddbec169429884f34b7f5111d27e_130)</u> | <u>[50](#i6a68ddbec169429884f34b7f5111d27e_130)</u> |
| <u>[Item 5.](#i6a68ddbec169429884f34b7f5111d27e_133)</u> | <u>[Other Information](#i6a68ddbec169429884f34b7f5111d27e_133)</u> | <u>[50](#i6a68ddbec169429884f34b7f5111d27e_133)</u> |
| <u>[Item 6.](#i6a68ddbec169429884f34b7f5111d27e_136)</u> | <u>[Exhibits](#i6a68ddbec169429884f34b7f5111d27e_136)</u> | <u>[52](#i6a68ddbec169429884f34b7f5111d27e_136)</u> |
|  | <u>[Signatures](#i6a68ddbec169429884f34b7f5111d27e_139)</u> | <u>[53](#i6a68ddbec169429884f34b7f5111d27e_139)</u> |

---

**Adient plc \| Form 10-Q \| 2**

------

**PART I - FINANCIAL INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Unaudited Financial Statements** |

---

**Adient plc**

**Consolidated Statements of Income (Loss)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions, except per share data)** | **2026** | **2025** | **2026** | **2025** |
| Net sales | $3865 | $3611 | $7509 | $7106 |
| Cost of sales | 3608 | 3350 | 7035 | 6629 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 257 | 261 | 474 | 477 |
| Selling, general and administrative expenses | 138 | 144 | 268 | 269 |
| Restructuring and impairment costs | 5 | 351 | 29 | 374 |
| Equity income | 13 | 18 | 40 | 43 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings (loss) before interest and income taxes | 127 | (216) | 217 | (123) |
| Net financing charges | 48 | 48 | 96 | 93 |
| Other pension expense | 3 | 1 | 4 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before income taxes | 76 | (265) | 117 | (218) |
| Income tax provision | 32 | 48 | 74 | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | 44 | (313) | 43 | (288) |
| Income attributable to noncontrolling interests | 17 | 22 | 38 | 47 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Adient | $27 | $(335) | $5 | $(335) |
| Earnings (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.34 | $(3.99) | $0.06 | $(3.98) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.34 | $(3.99) | $0.06 | $(3.98) |
| Shares used in computing earnings per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 78.4 | 84.0 | 78.5 | 84.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 79.3 | 84.0 | 79.4 | 84.2 |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 3**

------

**Adient plc**

**Consolidated Statements of Comprehensive Income (Loss)**

**(unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| Net income (loss) | $44 | $(313) | $43 | $(288) |
| Other comprehensive income, net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | (37) | 94 | (23) | (142) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Realized and unrealized gains (losses) on derivatives | (22) | 17 | (16) | 9 |
| Other comprehensive income (loss) | (59) | 111 | (39) | (133) |
| Total comprehensive income (loss) | (15) | (202) | 4 | (421) |
| Comprehensive income attributable to noncontrolling interests | 14 | 27 | 41 | 33 |
| Comprehensive loss attributable to Adient | $(29) | $(229) | $(37) | $(454) |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 4**

------

**Adient plc**

**Consolidated Statements of Financial Position**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| **(in millions, except share and per share data)** | **March 31, 2026** | **September 30, 2025** |
| **Assets** | | |
| Cash and cash equivalents | $831 | $958 |
| Accounts receivable - net | 2032 | 1873 |
| Inventories | 735 | 695 |
| Other current assets | 649 | 607 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current assets | 4247 | 4133 |
| Property, plant and equipment - net | 1384 | 1409 |
| Goodwill | 1798 | 1807 |
| Other intangible assets - net | 305 | 319 |
| Investments in partially-owned affiliates | 301 | 276 |
| Assets held for sale | 12 | 9 |
| Other noncurrent assets | 985 | 1001 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $9032 | $8954 |
| **Liabilities and Shareholders' Equity** |  |  |
| Short-term debt | $— | $2 |
| Current portion of long-term debt | 9 | 9 |
| Accounts payable | 2762 | 2549 |
| Accrued compensation and benefits | 351 | 393 |
| Other current liabilities | 748 | 734 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current liabilities | 3870 | 3687 |
| Long-term debt | 2379 | 2386 |
| Pension and postretirement benefits | 108 | 112 |
| Other noncurrent liabilities | 587 | 611 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Long-term liabilities | 3074 | 3109 |
| Commitments and Contingencies (Note 17) |  |  |
| Redeemable noncontrolling interests | 71 | 95 |
| Preferred shares issued, par value $0.001; 100,000,000 shares authorized,<br>Zero shares issued and outstanding at March 31, 2026 |  |  |
| Ordinary shares issued, par value $0.001; $500,000,000 shares authorized, <br>78,413,387 shares issued and outstanding at March 31, 2026 |  |  |
| Additional paid-in capital | 3586 | 3602 |
| Accumulated deficit | (1161) | (1166) |
| Accumulated other comprehensive loss | (712) | (670) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shareholders' equity attributable to Adient | 1713 | 1766 |
| Noncontrolling interests | 304 | 297 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 2017 | 2063 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and shareholders' equity | $9032 | $8954 |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 5**

------

**Adient plc**

**Consolidated Statements of Cash Flows**

**(unaudited)**

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** |
| **Operating Activities** |  |  |
| Net income (loss) attributable to Adient | $5 | $(335) |
| Income attributable to noncontrolling interests | 38 | 47 |
| Net income (loss) | 43 | (288) |
| Adjustments to reconcile net income to cash provided (used) by operating activities: | Adjustments to reconcile net income to cash provided (used) by operating activities: |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 137 | 136 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of intangibles | 23 | 23 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement expense | 8 | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pension and postretirement contributions, net | (8) | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity in earnings of partially-owned affiliates, net of dividends received | (12) | 14 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gain on sale of interests in nonconsolidated partially-owned affiliates |  | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (1) | 17 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-cash impairment charges |  | 343 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity-based compensation | 17 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 3 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities excluding impact of acquisitions/divestitures: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables | (168) | (37) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (48) | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (27) | (75) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | 193 | (106) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued income taxes | 1 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash provided by operating activities | 161 | 64 |
| **Investing Activities** |  |  |
| Capital expenditures | (138) | (109) |
| Sale of property, plant and equipment | 2 | 8 |
| Business divestitures |  | 27 |
| Investments in partially-owned affiliates | (6) | (3) |
| Other | (1) | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used by investing activities | (143) | (78) |
| **Financing Activities** |  |  |
| Drawdown of ABL revolver and other bank borrowings | 150 | 1 |
| Repayment of ABL revolver and other bank borrowings | (152) |  |
| Issuance of long-term debt |  | 795 |
| Repayment of long-term debt, including premium paid | (5) | (799) |
| Debt financing costs | (7) | (13) |
| Share repurchases | (25) | (25) |
| Acquisition of a noncontrolling interest |  | (28) |
| Dividends paid to and other transactions with noncontrolling interests | (77) | (77) |
| Share based compensation and other | (5) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash used by financing activities | (121) | (149) |
| Effect of exchange rate changes on cash and cash equivalents | (24) | (28) |
| **Decrease in cash and cash equivalents** | (127) | (191) |
| Cash and cash equivalents at beginning of period | 958 | 945 |
| Cash and cash equivalents at end of period | $831 | $754 |

---

**The accompanying notes are an integral part of the consolidated financial statements.**

**Adient plc \| Form 10-Q \| 6**

------

**Adient plc**

**Notes to Consolidated Financial Statements**

**(unaudited)**

**1. Organization and Summary of Significant Accounting Policies**

Adient is a global leader in the automotive seating supplier industry and maintains relationships with the largest global automotive original equipment manufacturers, or OEMs. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture, and deliver complete seat systems and components in every major automotive producing region in the world.

**Basis of Presentation**

The unaudited consolidated financial statements of Adient have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission and in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These interim consolidated financial statements include all adjustments (consisting of normal recurring adjustments) that management believes are necessary for a fair statement of the results of operations, financial position and cash flows of Adient for the interim periods presented. Certain figures for comparative periods were regrouped to conform to current period presentation.

**Principles of Consolidation**

Adient consolidates its wholly-owned subsidiaries and those entities in which it has a controlling interest. Investments in partially-owned affiliates are accounted for by the equity method when Adient does not have a controlling interest but is assessed to have significant influence on their operations.

*Consolidated VIEs*

Based upon the criteria set forth in the Financial Accounting Standards Board (the "FASB") Accounting Standards Codification ("ASC") 810, "Consolidation," Adient has determined that it was the primary beneficiary in two variable interest entities ("VIEs") for the reporting periods ended March 31, 2026, and September 30, 2025, as Adient absorbs significant economics of the entities and has the power to direct the activities that are considered most significant to the entities.

The two VIEs manufacture seating products in North America for the automotive industry. Adient funds the entities' short-term liquidity needs through revolving credit facilities and has the power to direct the activities that are considered most significant to the entities through its key customer supply relationships.

The carrying amounts and classification of assets (none of which are restricted) and liabilities included in Adient's consolidated statements of financial position for the consolidated VIEs are as follows:

---

| | | |
|:---|:---|:---|
| **(in millions)** | **March 31, 2026** | **September 30, 2025** |
| Current assets | $307 | $304 |
| Noncurrent assets | 92 | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $399 | $398 |
| Current liabilities | $258 | $257 |
| Noncurrent liabilities | 9 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $267 | $267 |

---

**Adient plc \| Form 10-Q \| 7**

------

**Earnings Per Share**

The following table shows the computations of basic and diluted earnings (loss) per share:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions, except per share data)** | **2026** | **2025** | **2026** | **2025** |
| **Income available to shareholders** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Adient | $27 | $(335) | $5 | $(335) |
| **Weighted average shares outstanding** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;**Basic weighted average shares outstanding** | 78.4 | 84.0 | 78.5 | 84.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;Effect of dilutive securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock options, unvested restricted stock and unvested performance share awards | 0.9 |  | 0.9 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted weight average shares outstanding | 79.3 | 84.0 | 79.4 | 84.2 |
| Earnings (loss) per share: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.34 | $(3.99) | $0.06 | $(3.98) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.34 | $(3.99) | $0.06 | $(3.98) |

---

The effect of common stock equivalents which would have been anti-dilutive was excluded, and immaterial, from the calculation of diluted earnings per share for the three and six months ended March 31, 2026. Potentially dilutive securities whose effect would have been anti-dilutive are excluded from the computation of diluted earnings per share for the three and six months ended March 31, 2025 as a result of being in a loss position.

**New Accounting Pronouncements**

*Standards to be Adopted During Fiscal 2026*

Adient adopted Accounting Standards Codification ("ASU") 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures* in fiscal 2026 which requires additional annual disclosures about the reporting entity's reconciliation of the effective tax rate to the statutory rate for federal, state, and foreign income taxes. The ASU also requires further disaggregation of income tax amounts paid by federal, state and foreign, as well as by material jurisdiction.

*Standards Effective After Fiscal 2026*

Adient has considered the new standards that are summarized below, each to be effective after fiscal 2026 which are not expected to significantly impact the consolidated financial statements:

---

| | | |
|:---|:---|:---|
| **Standard to be Adopted** | **Description** | **Date Effective** |
| ASU 2025-05 Measurement of Credit Losses for Accounts<br>Receivable and Contract Assets (Financial Instruments – Credit Losses (Topic 326)) | The ASU provides a practical expedient and an accounting policy election under which conditions at the period-end date can be assumed to remain unchanged for an asset's remaining life when estimating credit losses on current accounts receivable and current contract assets arising from transactions under ASC 606 Revenue from contracts with customers. The update is expected to simplify the credit loss assessment when applying Topic 326. | October 1, 2026 |
| ASU 2024-03 Income Statement - Reporting Comprehensive<br>Income - Expense: Disaggregation Disclosures<br>(Subtopic 220-40) | The ASU requires disclosures of specified information about certain costs and expenses in the notes to financial statements at each interim and annual reporting period, including: the amounts of purchases of inventory, employee compensation, depreciation, intangible asset amortization, and a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. It also requires disclosures of the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. | October 1, 2027 |

---

**Adient plc \| Form 10-Q \| 8**

------

---

| | | |
|:---|:---|:---|
| ASU 2025-06 Intangibles - Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software | The ASU amends the timing for capitalizing eligible internal use software costs. Under the new guidance, an entity is required to start capitalizing software costs when both of the following occur: 1) Management has authorized and committed to funding the software project; and 2) it is probable that the project will be completed and the software will be used to perform the function intended (referred to as the "probable-to-complete recognition threshold"). The ASU does not change the types of costs eligible for capitalization or the associated amortization and impairment guidance. | October 1, 2028 |
| ASU 2025-10 Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities | The ASU provides guidance over recognition, measurement and presentation of government grants received by public business entities. Under the ASU, a government grant is recognized when: 1) it is probable all conditions attached to the grant will be complied and the grant will be received; and 2) specific recognition guidance for the grant related to an asset or income is met. The benefit of the grant is in general recognized in earnings in a systematic and rational manner over the period in which the relevant expenses are recognized. | October 1, 2029 |

---

**2. Revenue Recognition**

Adient generates revenue through the sale of automotive seating solutions, including complete seating systems and the components of complete seating systems. Adient provides production and service parts to its customers under awarded multi-year programs. The duration of a program is generally consistent with the life cycle of a vehicle, however, the program can be canceled at any time without cause by the customer. Programs awarded to Adient to supply parts to its customers do not contain a firm commitment by the customer for volume or price and do not reach the level of a performance obligation until Adient receives either a purchase order and/or a materials release from the customer for a specific number of parts at a specified price, at which point an enforceable contract exists. Sales revenue is generally recognized at the point in time when parts are shipped and control has transferred to the customer, at which point an enforceable right to payment exists. Contracts may provide for annual price reductions over the production life of the awarded program, and prices are adjusted on an ongoing basis to reflect changes in product content/cost and other commercial factors. The amount of revenue recognized reflects the consideration that Adient expects to be entitled to in exchange for such products based on purchase orders, annual price reductions and ongoing price adjustments (some of which are accounted for as variable consideration and subject to being constrained), net of the impact, if any, of consideration paid to the customer. Approximately 1% of net sales recorded during the second quarter of fiscal 2026 were related to product sales transacted in prior periods.

In pursuit of new program awards, Adient at times agrees to make upfront payments to customers. Each time such a payment is made, Adient evaluates its nature, the underlying economics, legal and compliance ramifications, and other relevant factors and circumstances. These payments are deemed to be consideration payable to customers and are generally recognized as a reduction to revenue once mutually agreed. Certain upfront payments, however, are capitalized as other current and noncurrent assets if they are determined to be incremental, attributable only to the specific new program being awarded, and recoverable. As products under the new program are sold to the customer, the capitalized amount is amortized and recognized as a reduction to revenue over the term of the program, typically between three and seven years. Adient assesses recoverability of the capitalized amounts on an on-going basis. Any amounts that are concluded to be no longer recoverable are immediately recognized as a reduction to revenue. As of March 31, 2026 and September 30, 2025, Adient maintained capitalized upfront payments of $174 million and $174 million, respectively, within other noncurrent assets.

In a typical arrangement with the customer, purchase orders are issued for pre-production activities which consist of engineering, design and development, tooling and prototypes for the manufacture and delivery of component parts. Adient has concluded that these activities are not in the scope of ASC 606, "Revenue from Contracts with Customers."

Adient includes shipping and handling fees billed to customers in revenue, while including costs of shipping and handling in cost of sales. Taxes collected from customers are excluded from revenue and credited directly to obligations to the appropriate government agencies. Payment terms with customers are established based on customary industry and regional practices and do not contain significant financing components.

Contract assets primarily relate to the right to consideration for work completed, but not billed at the reporting date on contracts with customers. The contract assets are transferred to receivables when the rights become unconditional. Contract liabilities primarily relate to contracts where advance payments or deposits have been received, but performance obligations have not yet

**Adient plc \| Form 10-Q \| 9**

------

been satisfied and revenue has not been recognized. No material contract assets or liabilities exist at March 31, 2026 or at September 30, 2025. As described above, the issuance of a purchase order and/or a materials release by the customer represents the point at which an enforceable contract with the customer exists. Therefore, Adient has elected to apply the practical expedient in ASC 606 and does not disclose information about the remaining performance obligations that have an original expected duration of one year or less. Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for disaggregated revenue by geographical market.

**3. Acquisitions and Divestitures**

Subsequent to March 31, 2026, Adient acquired a foam manufacturing operation in the Americas for total purchase consideration of $11 million, of which $4 million was paid at closing in April 2026. The remaining consideration is expected to be paid during the first quarter of fiscal 2027.

During the first quarter of fiscal 2026, Adient invested $4 million to acquire 49% interest in a joint venture in China. The investment is expected to expand Adient's commercial and geographical footprint in China. The new investment is accounted for using the equity method of accounting and presented as part of investments in partially-owned affiliates on Adient's consolidated statements of financial position.

During the first quarter of fiscal 2025, Adient acquired all of the noncontrolling interest in Technotrim, Inc. ("Technotrim") for a value of $28 million and sold all of its partially-owned interests in Setex, Inc. and Setex SRL (together as "Setex") for a value of $27 million. The sale of Setex resulted in a one-time gain on sale of $4 million. The acquisition of all noncontrolling interest in Technotrim was recorded to equity. The transactions are expected to provide additional synergies through optimization of Adient's manufacturing footprint and additional control over its manufacturing presence in the Americas.

**4. Inventories**

Inventories consisted of the following:

---

| | | |
|:---|:---|:---|
| **(in millions)** | **March 31, 2026** | **September 30, 2025** |
| Raw materials and supplies | $560 | $522 |
| Work-in-process | 28 | 29 |
| Finished goods | 147 | 144 |
| Inventories | $735 | $695 |

---

**5. Goodwill and Other Intangible Assets**

The changes in the carrying amount of goodwill are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **(in millions)** | **Americas** | **EMEA** | **Asia** | **Total** |
| Balance at September 30, 2025 | $607 | $— | $1200 | $1807 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Currency translation | 1 |  | (10) | (9) |
| Balance at March 31, 2026 | $608 | $— | $1190 | $1798 |

---

Due to the continued and sustained decline in the market value of its ordinary shares during the second quarter of fiscal 2025 resulting from the uncertainties surrounding future production volume within the automotive industry, a triggering event was identified requiring a quantitative impairment analysis as of March 31, 2025. As a result, a $333 million non-cash goodwill impairment was recorded in the EMEA reporting unit during the quarter ended March 31, 2025. No amounts of goodwill remain recorded in EMEA.

**Adient plc \| Form 10-Q \| 10**

------

Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for more information on Adient's reportable segments.

Adient's other intangible assets, primarily from business acquisitions valued based on independent appraisals, consisted of:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **September 30, 2025** | **September 30, 2025** | **September 30, 2025** |
|<br>**(in millions)** | **Gross<br>Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net** | **Gross<br>Carrying<br>Amount** | **Accumulated<br>Amortization** | **Net** |
| Other intangible assets |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Patented technology | $80 | $(47) | $33 | $81 | $(45) | $36 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer relationships | 551 | (290) | 261 | 537 | (265) | 272 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 15 | (4) | 11 | 15 | (4) | 11 |
| Total other intangible assets | $646 | $(341) | $305 | $633 | $(314) | $319 |

---

Amortization of other intangible assets was $23 million for the six months ended March 31, 2026 and 2025.

**6. Product Warranties**

Adient offers warranties to its customers depending upon the specific product and terms of the customer purchase agreement. A typical warranty program requires that Adient replace defective products within a specified time period from the date of sale. Adient records an estimate for future warranty-related costs based on actual historical return rates and other known factors. Based on analysis of return rates and other factors, Adient's warranty provisions are adjusted as necessary. Adient monitors its warranty activity and adjusts its reserve estimates when it is probable that future warranty costs will be different than those estimates. Adient's product warranty liability is recorded in the consolidated statements of financial position in other current liabilities.

The changes in Adient's total product warranty liability are as follows:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended**<br>**March 31,** | **Six Months Ended**<br>**March 31,** |
|<br>**(in millions)** | **2026** | **2025** |
| Balance at beginning of period | $22 | $22 |
| Accruals for warranties issued during the period | 2 | 3 |
| Settlements/adjustments made (in cash or in kind) during the period | (5) | (5) |
| Balance at end of period | $19 | $20 |

---

**7. Leases**

Adient's lease portfolio consists of operating leases for real estate including production facilities, warehouses and administrative offices, equipment such as forklifts and computer servers and laptops, and fleet vehicles.

**Adient plc \| Form 10-Q \| 11**

------

The components of lease costs included in the consolidated statements of income (loss) for the three and six months ended March 31, 2026 and 2025 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| Operating lease cost | $28 | $27 | $56 | $54 |
| Short-term lease cost | 9 | 7 | 17 | 14 |
| Total lease cost | $37 | $34 | $73 | $68 |

---

Operating lease right-of-use assets and lease liabilities included in the consolidated statements of financial position were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | | **March 31, 2026** | **September 30, 2025** |
| **Operating leases:** | | | |
| Operating lease right-of-use assets | Other noncurrent assets | $255 | $259 |
| Operating lease liabilities - current | Other current liabilities | $82 | $82 |
| Operating lease liabilities - noncurrent | Other noncurrent liabilities | 172 | 176 |
|  |  | $254 | $258 |
| **Weighted average remaining lease term:** |  |  |  |
| Operating leases |  | 5 years | 5 years |
| **Weighted average discount rate:** |  |  |  |
| Operating leases |  | 6.4% | 6.0% |

---

Maturities of operating lease liabilities and minimum payments for operating leases having initial or remaining non-cancelable terms in excess of one year as of March 31, 2026 were as follows:

---

| | |
|:---|:---|
| **Fiscal years (in millions)** | **Operating Leases** |
| 2026 (excluding the six months ended March 31, 2026) | $51 |
| 2027 | 82 |
| 2028 | 58 |
| 2029 | 37 |
| 2030 | 25 |
| Thereafter | 47 |
| Total lease payments | 300 |
| Less: imputed interest | (46) |
| Present value of lease liabilities | $254 |

---

**Adient plc \| Form 10-Q \| 12**

------

Supplemental cash flow information related to leases was as follows:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** |
| Right-of-use assets obtained in exchange for lease obligations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating leases (non-cash activity) | $36 | $40 |
| Operating cash flows: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash paid for amounts included in the measurement of lease liabilities | $56 | $53 |

---

**8. Debt and Financing Arrangements**

Long-term and short-term debt consisted of the following:

---

| | | |
|:---|:---|:---|
| **(in millions)** | **March 31, 2026** | **September 30, 2025** |
| *Long-term debt:* |  |  |
| 8.25% Notes due 2031 | $500 | $500 |
| 7.00% Secured Notes due 2028 | 500 | 500 |
| Term Loan B due in 2031 | 622 | 626 |
| 7.50% Notes due in 2033 | 795 | 795 |
| Other bank borrowings and finance lease obligations | 6 | 5 |
| Less: debt issuance costs | (35) | (31) |
| Gross long-term debt | 2388 | 2395 |
| Less: current portion | 9 | 9 |
| Net long-term debt | $2379 | $2386 |
| *Short-term debt:* |  |  |
| Other bank borrowings | $— | $2 |
| Total short-term debt | $— | $2 |

---

As of September 30, 2025, Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintained an asset-based revolving credit facility (the "ABL Credit Facility"), which provided for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. During the first quarter of fiscal 2026, Adient amended the ABL Credit Facility, reducing the maximum facility from $1,250 million to $1,000 million (consisting of a North American subfacility of up to $895 million and a European subfacility of up to $105 million). Under the amended agreement, Adient will pay a commitment fee of 0.20% - 0.25% (previously 0.25% to 0.375%) on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Adient incurred $6 million of costs associated with this amendment, which was recorded as deferred financing costs. The amended ABL Credit Facility is set to mature in October 2030 (previously November 2027), subject to certain springing maturity provisions. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the amended ABL Credit Facility then in effect. Subject to certain conditions, the amended ABL Credit Facility may be expanded by up to $500 million in additional commitments. Loans under the amended ABL Credit Facility may be denominated, at the option of Adient, in U.S. Dollars, Euros, Pounds Sterling or Swedish Krona. It also provides flexibility for future amendments to the amended ABL Credit Facility to incorporate certain sustainability-based pricing provisions. The amended ABL Credit Facility is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. Interest is payable on the amended ABL Credit Facility at a fluctuating rate of interest determined by

**Adient plc \| Form 10-Q \| 13**

------

reference to Term SOFR, in the case of amounts outstanding in Dollars, EURIBOR, in the case of amounts outstanding in Euros, STIBOR, in the case of amounts outstanding in Swedish Krona and SONIA, in the case of amounts outstanding in Pounds Sterling, in each case, plus an applicable margin of 1.25% - 1.75% (previously 1.50% to 2.00%). During the second quarter of fiscal 2026, Adient drew down and fully repaid an aggregate of $150 million on the amended ABL Credit Facility. No amounts were outstanding as of March 31, 2026 under this facility, and total availability on that date was $957 million (net of $8 million of letters of credit).

In addition, Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintains a senior secured term loan facility (the "Term Loan B Agreement"), that had an outstanding balance of $622 million and $626 million as of March 31, 2026 and September 30, 2025, respectively. During the first quarter of fiscal 2025, the Term Loan B Agreement was amended to reduce the applicable margin from 2.75% to 2.25%. Adient incurred $1 million of costs associated with the modification, which was recorded as deferred financing costs. The maturity date was also extended from April 2028 to January 2031. The amended Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance due at final maturity. The amended Term Loan B Agreement permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. Interest on the amended Term Loan B Agreement accrues at Term SOFR plus an applicable margin. During the second quarter of fiscal 2026, Adient further amended the Term Loan B Agreement to reduce the applicable margin from 2.25% to 2.00%. Adient incurred $1 million of costs associated with this amendment, which was recorded as deferred financing costs.

The amended ABL Credit Facility and amended Term Loan B Agreement contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient's capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient's and its restricted subsidiaries' assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains (i) $500 million in aggregate principal amount of 7.00% senior secured notes due 2028, (ii) $500 million in aggregate principal amount of 8.250% senior unsecured notes due 2031 and (iii) $795 million in aggregate principal amount of 7.50% senior unsecured notes due 2033. Interest on notes (i) and (ii) are paid on April 15 and October 15 each year. Interest on note (iii) is paid on February 15 and August 15 each year. These notes contain covenants that are usual and customary.

**Net Financing Charges**

Adient's net financing charges in the consolidated statements of income (loss) contained the following components:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| Interest expense, net of capitalized interest costs | $49 | $48 | $101 | $95 |
| Banking fees and debt issuance cost amortization | 4 | 7 | 8 | 11 |
| Interest income | (6) | (6) | (14) | (13) |
| Net foreign exchange | 1 | (1) | 1 |  |
| Net financing charges | $48 | $48 | $96 | $93 |

---

Banking fees for the three and six months ended March 31, 2025 include $2 million of one-time accelerated-deferred financing fee charges associated with early redemption of previously outstanding notes. Total interest paid on both short and long-term debt for the six months ended March 31, 2026 and 2025 was $95 million and $84 million, respectively.

**Adient plc \| Form 10-Q \| 14**

------

**Other Arrangements**

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of March 31, 2026, $176 million was funded under these programs compared to $185 million as of September 30, 2025.

Adient also has a program with an external financial institution under which Adient's suppliers can sell their receivables from Adient to the financial institution at their sole discretion. Adient is not a party to the agreements between the participating suppliers and the financial institution. Adient's obligation under the program is to pay the original amounts of supplier invoices to the financial institution on the original invoice dates. No fees are paid and no assets are pledged by Adient. The payment terms for trade payables can range from 45 days to 120 days depending on types of services and goods being purchased. The payment terms for molds, dies and other tools that are acquired as part of pre-production activities are in general longer, and are normally dependent on the terms which Adient has agreed with its customers. As of March 31, 2026, Adient's liabilities related to this program were $107 million which is recorded within accounts payable ($16 million) and other current liabilities ($91 million) in Adient's consolidated statements of financial position. As of September 30, 2025, Adient's liabilities related to this program were $105 million which is recorded within accounts payable ($16 million) and other current liabilities ($89 million) in Adient's consolidated statements of financial position. Cash flows related to the program are all presented within operating activities in Adient's consolidated statements of cash flows.

**9. Derivative Instruments and Hedging Activities**

Adient selectively uses derivative instruments to reduce Adient's market risk associated with changes in foreign currency. Under Adient's policy, the use of derivatives is restricted to those intended for hedging purposes; the use of any derivative instrument for speculative purposes is strictly prohibited. A description of each type of derivative utilized to manage Adient's risk is included in the following paragraphs. In addition, refer to Note 10, "Fair Value Measurements," of the notes to the consolidated financial statements for information related to the fair value measurements and valuation methods utilized by Adient for each derivative type.

Adient has global operations and participates in the foreign exchange markets to minimize its risk of loss from fluctuations in foreign currency exchange rates. Adient primarily uses foreign currency exchange contracts to hedge certain foreign exchange rate exposures. Adient hedges 70% to 90% of the nominal amount of each of its known foreign exchange transactional exposures. Gains and losses on derivative contracts offset gains and losses on underlying foreign currency exposures. These contracts have been designated as cash flow hedges under ASC 815, "Derivatives and Hedging," and the hedge gains or losses due to changes in fair value are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. All contracts were highly effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at March 31, 2026 and September 30, 2025, respectively.

Adient also utilizes foreign currency exchange contracts and cross currency interest rate swap contracts to selectively hedge portions of its investments in foreign subsidiaries. Such contracts are designated as net investment hedges, with the objective of managing the impact of foreign currency exchange rate fluctuations on Adient's net investments. The currency effects of such contracts are reflected in the AOCI account within shareholders' equity attributable to Adient, where gains and losses recorded on Adient's net investment are offset.

During the first quarter of fiscal 2026, Adient entered into a cross-currency interest rate swap agreement with an aggregate notional amount of $60 million in order to hedge the foreign currency risk associated with its net investment in Japanese subsidiaries. The agreement will expire during the first quarter of fiscal 2027 and has been designated as a net investment hedge of Adient's Japanese yen denominated subsidiaries. The currency remeasurement impacts of the instruments are reflected in the AOCI account within shareholders' equity attributable to Adient where they offset gains and losses recorded on Adient's net investment. Under the terms of the agreement, Adient receives fixed-rate interest payments in U.S. dollar at a rate of 2.85% and pays 0.00% on the fixed-rate yen leg. The interest rate differentials are recorded within net financing charges on the consolidated statement of income (loss).

During the fourth quarter of fiscal 2025, Adient entered into cross-currency interest rate swap agreements with an aggregate notional amount of $325 million in order to hedge the foreign currency risk associated with its net investment in European subsidiaries. These agreements expire over a three-year period and have been designated as net investment hedges of Adient's

**Adient plc \| Form 10-Q \| 15**

------

Euro denominated subsidiaries. Under the terms of the agreements, Adient receives fixed-rate interest payments in U.S. dollar at a weighted average rate of 1.85% and pays 0.00% on the fixed-rate Euro leg. The interest rate differentials are recorded within net financing charges on the consolidated statement of income (loss).

During the third quarter of fiscal 2025, Adient entered into a ¥559 million ($78 million) foreign currency exchange contract to selectively hedge portions of its net investment in China. The contract is set to mature in October 2026.

During the third quarter of fiscal 2024, Adient entered into a ¥570 million ($78 million) foreign currency exchange contract to selectively hedge portions of its net investment in China. During the first quarter of fiscal 2026, ¥413 million ($58 million) of the notional amount have matured, the impact of which was not material. The remainder of the contract is set to mature in June 2026.

During the second quarter of fiscal 2024, Adient entered into a ¥685 million ($96 million) foreign exchange forward contract to selectively hedge portions of its net investment in China. The contract matured during the first quarter of fiscal 2025, the impact of which was not material.

The following table presents the location and fair values of derivative instruments and other amounts used in hedging activities included in Adient's consolidated statements of financial position:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Derivatives and Hedging<br>Activities Designated as<br>Hedging Instruments<br>under ASC 815** | **Derivatives and Hedging<br>Activities Designated as<br>Hedging Instruments<br>under ASC 815** | **Derivatives and Hedging<br>Activities Not Designated as<br>Hedging Instruments<br>under ASC 815** | **Derivatives and Hedging<br>Activities Not Designated as<br>Hedging Instruments<br>under ASC 815** |
| <br>**(in millions)** | **March 31, 2026** | **September 30, 2025** | **March 31, 2026** | **September 30, 2025** |
| Other current assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $25 | $32 | $— | $4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 4 |  |  |  |
| Other noncurrent assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives |  | 1 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 1 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $30 | $33 | $— | $4 |
| Other current liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $13 | $7 | $2 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps |  | 1 |  |  |
| Other noncurrent liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 6 | 2 |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps |  | 3 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $19 | $13 | $2 | $1 |

---

Adient enters into International Swaps and Derivatives Associations ("ISDA") master netting agreements with counterparties that permit the net settlement of amounts owed under the derivative contracts. The master netting agreements generally provide for net settlement of all outstanding contracts with a counterparty in the case of an event of default or a termination event. Adient has not elected to offset the fair value positions of the derivative contracts recorded in the consolidated statements of financial position. Collateral is generally not required of Adient or the counterparties under the master netting agreements. As of March 31, 2026 and September 30, 2025, no cash collateral was received or pledged under the master netting agreements.

The gross and net amounts of derivative instruments and other amounts used in hedging activities are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Assets** | **Assets** | **Liabilities** | **Liabilities** |
|<br>**(in millions)** | **March 31, 2026** | **September 30, 2025** | **March 31, 2026** | **September 30, 2025** |
| Gross amount recognized | $30 | $37 | $21 | $14 |
| Gross amount eligible for offsetting | (18) | (10) | (18) | (10) |
| Net amount | $12 | $27 | $3 | $4 |

---

**Adient plc \| Form 10-Q \| 16**

------

The following table presents the effective portion of pretax gains (losses) recorded in other comprehensive income (loss) related to cash flow hedges:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
| **(in millions)** | **2026** | **2025** | **2026** | **2025** |
| Foreign currency exchange derivatives | $(5) | $13 | $15 | $(1) |

---

The following table presents the location and amount of the effective portion of pretax gains (losses) on cash flow hedges reclassified from AOCI into Adient's consolidated statements of income (loss):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in millions)** | | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
| **(in millions)** | | **2026** | **2025** | **2026** | **2025** |
| Foreign currency exchange derivatives | Cost of sales | $18 | $(9) | $30 | $(17) |

---

During the next twelve months, $15 million of pretax gain on cash flow hedges are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).

The following table presents the location and amount of pretax gains (losses) on derivatives not designated as hedging instruments recognized in Adient's consolidated statements of income (loss):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in millions)** | | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
| **(in millions)** | | **2026** | **2025** | **2026** | **2025** |
| Foreign currency exchange derivatives | Cost of sales | $(2) | $3 | $(2) | $— |
| Foreign currency exchange derivatives | Net financing charges | (4) | (1) |  | (14) |
| Total |  | $(6) | $2 | $(2) | $(14) |

---

The effective portion of pretax gains (losses) recorded in currency translation adjustment ("CTA") within other comprehensive income (loss) related to net investment hedges was $6 million and $(1) million for the three months ended March 31, 2026 and 2025, respectively, and $6 million and $3 million for the six months ended March 31, 2026 and 2025, respectively. For the three and six months ended March 31, 2026 and 2025, respectively, no significant gains or losses were reclassified from CTA into income for Adient's outstanding net investment hedges.

For the three and six months ended March 31, 2026 and 2025, no ineffectiveness was recognized in the consolidated statements of income (loss) resulting from cash flow hedges.

**10. Fair Value Measurements**

ASC 820, "Fair Value Measurement," defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a three-level fair value hierarchy that prioritizes information used in developing assumptions when pricing an asset or liability as follows:

*Level 1:* Observable inputs such as quoted prices in active markets;

*Level 2:* Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

*Level 3:* Unobservable inputs where there is little or no market data, which requires the reporting entity to develop its own assumptions.

**Adient plc \| Form 10-Q \| 17**

------

ASC 820 requires the use of observable market data, when available, in making fair value measurements. When inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement.

**Recurring Fair Value Measurements**

The following tables present Adient's fair value hierarchy for those assets and liabilities measured at fair value:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** |
|<br>**(in millions)** | **Total as of** <br>**March 31, 2026** | **Quoted Prices<br>in Active<br>Markets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** |
| Other current assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $25 | $— | $25 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 4 |  | 4 |  |
| Other noncurrent assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 1 |  | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $30 | $— | $30 | $— |
| Other current liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $15 |  | $15 |  |
| Other noncurrent liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 6 |  | 6 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $21 | $— | $21 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** | **Fair Value Measurements Using:** |
|<br>**(in millions)** | **Total as of**<br>**September 30, 2025** | **Quoted Prices<br>in Active<br>Markets<br>(Level 1)** | **Significant<br>Other<br>Observable<br>Inputs<br>(Level 2)** | **Significant<br>Unobservable<br>Inputs<br>(Level 3)** |
| Other current assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $36 | $— | $36 | $— |
| Other noncurrent assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 1 |  | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $37 | $— | $37 | $— |
| Other current liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | $7 | $— | $7 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 1 |  | 1 |  |
| Other noncurrent liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange derivatives | 3 |  | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cross-currency interest rate swaps | 3 |  | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $14 | $— | $14 | $— |

---

**Valuation Methods**

*Foreign currency exchange derivatives:* Adient selectively hedges anticipated transactions and net investments that are subject to foreign exchange rate risk primarily using foreign currency exchange hedge contracts. The foreign currency exchange derivatives are valued under a market approach using publicized spot and forward prices. Changes in fair value on foreign exchange derivatives accounted for as hedging instruments under ASC 815 are initially recorded as a component of AOCI and are subsequently reclassified into earnings when the hedged transactions occur and affect earnings. These contracts were highly

**Adient plc \| Form 10-Q \| 18**

------

effective in hedging the variability in future cash flows attributable to changes in currency exchange rates at March 31, 2026 and September 30, 2025, respectively. The changes in fair value of foreign currency exchange derivatives not designated as hedging instruments under ASC 815 are recorded in the consolidated statements of income (loss).

The fair value of cash and cash equivalents, accounts receivable, short-term debt and accounts payable approximate their carrying values. The fair value of long-term debt, which was $2.4 billion and $2.5 billion at March 31, 2026 and September 30, 2025, respectively, was determined primarily using market quotes classified as Level 1 inputs within the ASC 820 fair value hierarchy.

**11. Equity and Noncontrolling Interests**

For the three months ended March 31, 2026:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Ordinary Shares** | **Additional Paid-in Capital** | **Retained Earnings<br>(Accumulated Deficit)** | **Accumulated Other Comprehensive Income (Loss)** | **Shareholders' Equity Attributable<br> to Adient** | **Shareholders' Equity Attributable to Noncontrolling Interests** | **Total Equity** |
| **Balance at December 31, 2025** | $**—** | $**3579** | $**(1188)** | $**(656)** | $**1735** | $**294** | $**2029** |
| Net income |  |  | 27 |  | **27** | 9 | **36** |
| Foreign currency translation adjustments |  |  |  | (34) | **(34)** | 2 | **(32)** |
| Realized and unrealized losses on derivatives |  |  |  | (22) | **(22)** |  | **(22)** |
| Dividends attributable to noncontrolling interests |  |  |  |  | **—** | (1) | **(1)** |
| Share based compensation and other |  | 7 |  |  | **7** |  | **7** |
| **Balance at March 31, 2026** | $**—** | $**3586** | $**(1161)** | $**(712)** | $**1713** | $**304** | $**2017** |

---

For the six months ended March 31, 2026:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Ordinary Shares** | **Additional Paid-in Capital** | **Retained Earnings<br>(Accumulated Deficit)** | **Accumulated Other Comprehensive Income (Loss)** | **Shareholders' Equity Attributable<br> to Adient** | **Shareholders' Equity Attributable to Noncontrolling Interests** | **Total Equity** |
| **Balance at September 30, 2025** | $**—** | $**3602** | $**(1166)** | $**(670)** | $**1766** | $**297** | $**2063** |
| Net income |  |  | 5 |  | **5** | 21 | **26** |
| Foreign currency translation adjustments |  |  |  | (26) | **(26)** | 5 | **(21)** |
| Realized and unrealized losses on derivatives |  |  |  | (16) | **(16)** |  | **(16)** |
| Dividends attributable to noncontrolling interests |  |  |  |  | **—** | (19) | **(19)** |
| Repurchases of common stock |  | (25) |  |  | **(25)** |  | **(25)** |
| Share based compensation and other |  | 9 |  |  | **9** |  | **9** |
| **Balance at March 31, 2026** | $**—** | $**3586** | $**(1161)** | $**(712)** | $**1713** | $**304** | $**2017** |

---

**Adient plc \| Form 10-Q \| 19**

------

For the three months ended March 31, 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Ordinary Shares** | **Additional Paid-in Capital** | **Retained Earnings<br>(Accumulated Deficit)** | **Accumulated Other Comprehensive Income (Loss)** | **Shareholders' Equity Attributable<br> to Adient** | **Shareholders' Equity Attributable to Noncontrolling Interests** | **Total Equity** |
| **Balance at December 31, 2024** | $**—** | $**3682** | $**(885)** | $**(920)** | $**1877** | $**284** | $**2161** |
| Net income (loss) |  |  | (335) |  | **(335)** | 14 | **(321)** |
| Foreign currency translation adjustments |  |  |  | 89 | **89** | 4 | **93** |
| Realized and unrealized gains on derivatives |  |  |  | 17 | **17** |  | **17** |
| Dividends attributable to noncontrolling interests |  |  |  |  | **—** | (5) | **(5)** |
| Share based compensation and other |  | 4 |  |  | **4** |  | **4** |
| **Balance at March 31, 2025** | $**—** | $**3686** | $**(1220)** | $**(814)** | $**1652** | $**297** | $**1949** |

---

For the six months ended March 31, 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Ordinary Shares** | **Additional Paid-in Capital** | **Retained Earnings<br>(Accumulated Deficit)** | **Accumulated Other Comprehensive Income (Loss)** | **Shareholders' Equity Attributable<br> to Adient** | **Shareholders' Equity Attributable to Noncontrolling Interests** | **Total Equity** |
| **Balance at September 30, 2024** | $**—** | $**3712** | $**(885)** | $**(693)** | $**2134** | $**309** | $**2443** |
| Net income (loss) |  |  | (335) |  | **(335)** | 29 | **(306)** |
| Foreign currency translation adjustments |  |  |  | (128) | **(128)** | (7) | **(135)** |
| Realized and unrealized gains (losses) on derivatives |  |  |  | 9 | **9** |  | **9** |
| Dividends attributable to noncontrolling interests |  |  |  |  | **—** | (15) | **(15)** |
| Purchase of noncontrolling interest <sup>(1)</sup> |  | (7) |  | (2) | **(9)** | (19) | **(28)** |
| Repurchases of common stock |  | (25) |  |  | **(25)** |  | **(25)** |
| Share based compensation and other |  | 6 |  |  | **6** |  | **6** |
| **Balance at March 31, 2025** | $**—** | $**3686** | $**(1220)** | $**(814)** | $**1652** | $**297** | $**1949** |

---

<sup>(1)</sup> Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.

**Adient plc \| Form 10-Q \| 20**

------

The following table presents changes in AOCI attributable to Adient:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| **Foreign currency translation adjustments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | $(679) | $(892) | $(687) | $(673) |
| &nbsp;&nbsp;&nbsp;&nbsp;Aggregate adjustment for the period, net of tax | (34) | 89 | (26) | (130) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period <sup>(1)</sup> | $(713) | $(803) | $(713) | $(803) |
| **Realized and unrealized gains (losses) on derivatives** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | $24 | $(27) | $18 | $(19) |
| &nbsp;&nbsp;&nbsp;&nbsp;Current period changes in fair value, net of tax | (9) | 11 | 7 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;Reclassification to income, net of tax | (13) | 6 | (23) | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | $2 | $(10) | $2 | $(10) |
| **Pension and postretirement plans** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of period | $(1) | $(1) | $(1) | $(1) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of period | $(1) | $(1) | $(1) | $(1) |
| Accumulated other comprehensive loss, end of period | $(712) | $(814) | $(712) | $(814) |

---

<sup>(1)</sup> Foreign currency translation adjustments as of March 31, 2026 and 2025 include (losses) gains on designated net investment hedge instruments of $1 million and $0 million, respectively. During the next twelve months, no gains or losses are expected to be reclassified from AOCI into Adient's consolidated statements of income (loss).

Adient consolidates certain subsidiaries in which the noncontrolling interest party has within their control the right to require Adient to redeem all or a portion of its interest in the subsidiary. These redeemable noncontrolling interests are reported at their estimated redemption value. Any adjustment to the redemption value impacts retained earnings but does not impact net income. Redeemable noncontrolling interests which are redeemable only upon future events, the occurrence of which is not currently probable, are recorded at carrying value. The following table presents changes in the redeemable noncontrolling interests:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| Beginning balance | $68 | $62 | $95 | $91 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | 8 | 8 | 17 | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends |  |  | (39) | (31) |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | (5) | 1 | (2) | (7) |
| Ending balance | $71 | $71 | $71 | $71 |

---

**Repurchases of Equity Securities**

In November 2022, Adient's board of directors authorized the repurchase of Adient's ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient's ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. From fiscal 2023 through fiscal 2025, Adient repurchased and immediately retired a total of 17,297,377 ordinary shares. The aggregate amount of cash paid to repurchase the shares was $465 million, all of which had been spent through September 30, 2025. During the first quarter of fiscal 2026, Adient repurchased and immediately retired 1,232,932 of its ordinary shares at an average purchase price per share of $20.27, for an aggregate amount of cash paid of $25 million. No shares were repurchased during the second quarter of fiscal 2026. As of March 31, 2026, the remaining aggregate amount of authorization remaining under the share repurchase authorization was $110 million.

**Adient plc \| Form 10-Q \| 21**

------

**12. Retirement Plans**

Adient maintains non-contributory defined benefit pension plans covering primarily non-U.S. employees and a limited number of U.S. employees. The following table contains the components of net periodic benefit cost:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| Service cost | $2 | $2 | $4 | $3 |
| Interest cost | 5 | 5 | 9 | 9 |
| Expected return on plan assets | (4) | (4) | (7) | (7) |
| Net actuarial and settlement/curtailment loss | 2 |  | 2 |  |
| Net periodic benefit cost | $5 | $3 | $8 | $5 |

---

The interest cost, expected return on plan assets, and net actuarial and settlement/curtailment (gain) loss components of net periodic benefit cost are included in other pension expense in the consolidated statements of income (loss).

**13. Restructuring and Impairment Costs**

*Restructuring*

To better align its resources with its overall strategies and reduce the cost structure of its global operations to address the softness in certain underlying markets, Adient commits to restructuring plans as necessary. Adient, in general, records costs associated with separation programs when management has approved the plan for separation, the affected employees are identified, and it is unlikely that actions required to complete the separation plan will change significantly. Costs associated with benefits that are contingent on the employee continuing to provide service are accrued over the required service period. All other costs associated with restructuring activities are expensed as incurred.

During the first six months of fiscal 2026, Adient committed to restructuring actions ("2026 Plan") resulting in charges of $28 million and an additional $1 million related to prior year plans. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA. The 2026 Plan is being implemented in response to manufacturing footprint and structural changes occurring in the global automotive industry and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with the 2026 Plan will primarily occur in fiscal years 2026 and 2027, and are expected to be substantially complete by fiscal year 2027. Restructuring costs are included in restructuring and impairment costs in the consolidated statements of income (loss). The following tables summarize the changes in Adient's restructuring reserve.

**Adient plc \| Form 10-Q \| 22**

------

For the three months ended March 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | **Employee Severance and Termination Benefits** | **Currency<br>Translation** | **Total** |
| Balance at December 31, 2025 | $136 | $6 | $142 |
| &nbsp;&nbsp;&nbsp;2026 Plan charges | 5 |  | 5 |
| &nbsp;&nbsp;&nbsp;Utilized - cash | (15) |  | (15) |
| &nbsp;&nbsp;&nbsp;Noncash and other adjustments |  | (3) | (3) |
| Balance at March 31, 2026 | $126 | $3 | $129 |
| Current restructuring reserve - other current liabilities |  |  | $86 |
| Noncurrent restructuring reserve - other noncurrent liabilities |  |  | 43 |
| Balance at March 31, 2026 |  |  | $129 |

---

For the six months ended March 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | **Employee Severance and Termination Benefits** | **Currency<br>Translation** | **Total** |
| Balance at September 30, 2025 | $128 | $6 | $134 |
| &nbsp;&nbsp;&nbsp;2026 Plan charges | 28 |  | 28 |
| &nbsp;&nbsp;&nbsp;Utilized - cash | (31) |  | (31) |
| &nbsp;&nbsp;&nbsp;Noncash and other adjustments | 1 | (3) | (2) |
| Balance at March 31, 2026 | $126 | $3 | $129 |

---

During the first six months of fiscal 2025, Adient committed to restructuring actions ("2025 Plan") resulting in charges of $33 million, which was offset by $2 million of prior-year underspend. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA. The 2025 Plan is being implemented in response to manufacturing footprint and structural changes occurring in the global automotive industry and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with these specific plans have occurred and will primarily occur in fiscal years 2025 and 2026 and are expected to be substantially complete by fiscal year 2027. Restructuring costs are included in restructuring and impairment costs in the consolidated statements of income (loss). The following tables summarize the changes in Adient's restructuring reserve.

**Adient plc \| Form 10-Q \| 23**

------

For the three months ended March 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | **Employee Severance and Termination Benefits** | **Currency<br>Translation** | **Total** |
| Balance at December 31, 2024 | $165 | $(11) | $154 |
| &nbsp;&nbsp;&nbsp;2025 Plan charges | 24 |  | 24 |
| &nbsp;&nbsp;&nbsp;Utilized - cash | (28) |  | (28) |
| &nbsp;&nbsp;&nbsp;Noncash and other adjustments | (6) | 8 | 2 |
| Balance at March 31, 2025 | $155 | $(3) | $152 |
| Current restructuring reserve - other current liabilities |  |  | $91 |
| Noncurrent restructuring reserve - other noncurrent liabilities |  |  | 61 |
| Balance at March 31, 2025 |  |  | $152 |

---

For the six months ended March 31, 2025:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | **Employee Severance and Termination Benefits** | **Currency<br>Translation** | **Total** |
| Balance at September 30, 2024 | $181 | $1 | $182 |
| &nbsp;&nbsp;&nbsp;2025 Plan charges | 33 |  | 33 |
| &nbsp;&nbsp;&nbsp;Utilized - cash | (57) |  | (57) |
| &nbsp;&nbsp;&nbsp;Noncash and other adjustments | (2) | (4) | (6) |
| Balance at March 31, 2025 | $155 | $(3) | $152 |

---

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low-cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Future adverse developments in the automotive industry could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

*Impairment*

During the first six months of fiscal 2025, Adient recorded a non-cash impairment loss of $10 million on its investment in Adient Aerospace. The impairment is included in restructuring and impairment costs in the consolidated statements of income (loss). Refer also to Note 5, "Goodwill and Other Intangible Assets" of the notes to the consolidated financial statements for information about the EMEA goodwill impairment recorded during fiscal 2025.

**14. Income Taxes**

In calculating the provision for income taxes, Adient uses an estimate of the annual effective tax rate based upon the facts and circumstances known at each interim period. On a quarterly basis, the actual effective tax rate is adjusted, as appropriate, based on changes in facts and circumstances, if any, as compared to those forecasted at the beginning of the fiscal year and each interim period thereafter. For the three and six months ended March 31, 2026, Adient's income tax expense was $32 million equating to an effective tax rate of 42% and $74 million equating to an effective tax rate of 63%, respectively. The three month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by tax benefits related to statute expirations. The six month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances and the establishment of uncertain tax positions as a result of initiating a foreign tax audit settlement, partially offset by tax benefits related to audit closures and statute expirations. For the three and six months ended March 31, 2025, Adient's income tax expense was $48 million equating to an effective tax rate of (18)% and

**Adient plc \| Form 10-Q \| 24**

------

$70 million equating to an effective tax rate of (32)%, respectively. The three month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, tax expense related to adjustments to net operating loss deferred tax assets and uncertain tax positions, and the impact of the impairment of the non-tax-deductible portion of the EMEA goodwill balance for which there is no corresponding income tax benefit. The six month income tax expense was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, tax expense related to adjustments to net operating loss deferred tax assets and uncertain positions, and the impact of the impairment of the non-tax-deductible portion of the EMEA goodwill balance for which there is no corresponding income tax benefit, partially offset by tax benefits from the release of uncertain tax positions due to statute expirations.

**Valuation Allowances**

As a result of Adient's second quarter fiscal 2026 analysis of the realizability of its worldwide deferred tax assets, and after considering tax planning initiatives and other positive and negative evidence, Adient determined that no changes to valuation allowances were required.

Adient reviews the realizability of its deferred tax assets on a quarterly basis, or whenever events or changes in circumstances indicate that a review is required. In determining the requirement for a valuation allowance, the historical and projected financial results of the legal entity or combined group recording the net deferred tax asset are considered, along with any other positive or negative evidence. All of the factors that Adient considers in evaluating whether and when to establish or release all or a portion of the deferred tax asset valuation allowance involve significant judgment. Since future financial results may differ from previous estimates, periodic adjustments to Adient's valuation allowances may be necessary.

Given current earnings and anticipated future earnings at certain subsidiaries, Adient believes that there is a reasonable possibility that sufficient positive evidence may become available that would allow the release of all, or a portion of, valuation allowances at certain subsidiaries within the next twelve months. A release of valuation allowances, if any, would result in the recognition of certain deferred tax assets which could generate a material income tax benefit for the period in which such release is recorded.

**Uncertain Tax Positions**

At March 31, 2026, Adient had gross tax effected unrecognized tax benefits of $335 million. If recognized, $105 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at March 31, 2026 was approximately $22 million (net of tax benefit). The interest and penalties accrued for the three and six months ended March 31, 2026 was $2 million and $16 million, respectively. During the three months ended March 31, 2026, Adient recognized tax benefits of $3 million related to the release of uncertain tax positions due to statute expirations. During the six months ended March 31, 2026, Adient recognized $22 million of tax expense (including $12 million of interest and penalties) as a result of initiating a foreign tax audit settlement and tax benefits of $13 million related to the release of uncertain tax positions due to audit closures and statute expirations. At September 30, 2025, Adient had gross tax effected unrecognized tax benefits of $404 million. If recognized, $114 million of Adient's unrecognized tax benefits would impact the effective tax rate. Total net accrued interest at September 30, 2025 was approximately $21 million (net of tax benefit). The interest and penalties accrued for the three and six months ended March 31, 2025 was $1 million and $1 million, respectively. Additionally, during the three months ended March 31, 2025, Adient recognized tax expense of $9 million to establish a reserve for an uncertain tax position. During the six months ended March 31, 2025, Adient recognized tax benefits of $7 million related to the release of uncertain tax positions due to statute expirations as well as tax expense of $9 million to establish a reserve for an uncertain tax position. Adient recognizes interest and penalties related to unrecognized tax benefits as a component of income tax expense.

**Other**

During the three and six months ended March 31, 2025, Adient recognized tax expense of $19 million related to adjustments to net operating loss deferred tax assets. In addition, Adient recognized a net tax benefit of $13 million related to the impairment of tax-deductible goodwill in Europe during the three and six months ended March 31, 2025.

The Organization for Economic Cooperation and Development's Pillar Two initiative, which introduced a 15% global minimum tax applied on a country by country basis, was applicable for Adient beginning in fiscal 2025. Adient has estimated the annual effect of these rules and the impact on Adient's effective tax rate is not material. Adient will continue to monitor and evaluate new legislation and guidance related to Pillar Two, including the OECD's administrative guidance published on

**Adient plc \| Form 10-Q \| 25**

------

January 5, 2026, which could change our current assessment.

On July 4, 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law. The OBBBA makes permanent key elements of the Tax Cuts and Jobs Act, including 100% bonus depreciation, domestic research cost expensing, and the business interest expense limitation. ASC 740 requires the effects of changes in tax rates and laws to be recognized in the period in which the legislation is enacted. The OBBBA did not have a material impact on Adient's consolidated financial statements.

**15. Segment Information**

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East, and Africa ("EMEA"); and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring-related costs, net mark-to-market adjustments on pension plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

The President and Chief Executive Officer is Adient's chief operating decision maker ("CODM"). The CODM evaluates the performance of the reportable segments using Adjusted EBITDA. Adjusted EBITDA is used for forecasting and to measure periodic performance and cash flow generation of the reportable segments and to make capital allocation decisions within the operations that ultimately provide shareholder returns.

The following tables summarize Adient's reportable segments' sales and Adjusted EBITDA for the three and six months ended March 31, 2026 and 2025, respectively, which include significant expenses that align with the segment-level information that is regularly provided to the CODM. The reportable segments' Adjusted EBITDA is reconciled to income (loss) before income taxes.

**Adient plc \| Form 10-Q \| 26**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**March 31, 2026** | **Three Months Ended**<br>**March 31, 2026** | **Three Months Ended**<br>**March 31, 2026** | **Three Months Ended**<br>**March 31, 2026** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Consolidated** |
| Segment net sales | $1884 | $1272 | $734 | $3890 |
| &nbsp;&nbsp;Eliminations |  |  |  | (25) |
| Consolidated net sales |  |  |  | $3865 |
| Material costs | 1221 | 770 | 517 |  |
| Labor and overhead | 508 | 407 | 109 |  |
| Administrative, engineering and allocated costs | 46 | 54 | 26 |  |
| Equity income |  | 4 | 10 |  |
| Adjusted EBITDA | $109 | $45 | $92 | $246 |
| *Reconciliation to income (loss) before income taxes* |  |  |  |  |
| Corporate-related costs <sup>(1)</sup> |  |  |  | (23) |
| Restructuring and impairment costs <sup>(2)</sup> |  |  |  | (5) |
| Purchase accounting amortization <sup>(3)</sup> |  |  |  | (12) |
| Restructuring-related activities <sup>(4)</sup> |  |  |  | (6) |
| Depreciation expense |  |  |  | (68) |
| Equity based compensation |  |  |  | (9) |
| Other items <sup>(5)</sup> |  |  |  | 4 |
| Net financing charges |  |  |  | (48) |
| Other pension expense |  |  |  | (3) |
| Income (loss) before income taxes |  |  |  | 76 |

---

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects $5 million of restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities, including $5 million of restructuring-related charges primarily recorded in cost of sales and $1 million of restructuring charges at partially-owned affiliates recorded within equity income.

(5) Includes a $5 million one-time, non-recurring reversal of contingent liabilities with a customer recorded in cost of sales, partially offset by $1 million of transaction costs recorded in SG&A.

**Adient plc \| Form 10-Q \| 27**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended**<br>**March 31, 2026** | **Six Months Ended**<br>**March 31, 2026** | **Six Months Ended**<br>**March 31, 2026** | **Six Months Ended**<br>**March 31, 2026** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Consolidated** |
| Segment net sales | $3526 | $2477 | $1553 | $7556 |
| &nbsp;&nbsp;Eliminations |  |  |  | (47) |
| Consolidated net sales |  |  |  | $7509 |
| Material costs | 2262 | 1512 | 1098 |  |
| Labor and overhead | 990 | 788 | 224 |  |
| Administrative, engineering and allocated costs | 85 | 107 | 58 |  |
| Equity income |  | 9 | 34 |  |
| Adjusted EBITDA | $189 | $79 | $207 | $475 |
| *Reconciliation to income (loss) before income taxes* |  |  |  |  |
| Corporate-related costs <sup>(1)</sup> |  |  |  | (45) |
| Restructuring and impairment costs <sup>(2)</sup> |  |  |  | (29) |
| Purchase accounting amortization <sup>(3)</sup> |  |  |  | (23) |
| Restructuring-related activities <sup>(4)</sup> |  |  |  | (13) |
| Depreciation expense |  |  |  | (137) |
| Equity based compensation |  |  |  | (17) |
| Other items <sup>(5)</sup> |  |  |  | 6 |
| Net financing charges |  |  |  | (96) |
| Other pension expense |  |  |  | (4) |
| Income (loss) before income taxes |  |  |  | 117 |

---

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects $29 million of restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities, including $10 million of restructuring-related charges primarily recorded in cost of sales and $3 million of restructuring charges at partially-owned affiliates recorded within equity income.

(5) Includes a $5 million one-time, non-recurring reversal of contingent liabilities with a customer recorded in cost of sales and a $2 million gain on a non-recurring contract related settlement recorded in SG&A, partially offset by $1 million of transaction costs recorded in SG&A.

**Adient plc \| Form 10-Q \| 28**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended**<br>**March 31, 2025** | **Three Months Ended**<br>**March 31, 2025** | **Three Months Ended**<br>**March 31, 2025** | **Three Months Ended**<br>**March 31, 2025** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Consolidated** |
| Segment net sales | $1699 | $1231 | $707 | $3637 |
| &nbsp;&nbsp;Eliminations |  |  |  | (26) |
| Consolidated net sales |  |  |  | $3611 |
| Material costs | 1104 | 755 | 481 |  |
| Labor and overhead | 454 | 378 | 98 |  |
| Administrative, engineering and allocated costs | 47 | 51 | 34 |  |
| Equity income |  | 3 | 16 |  |
| Adjusted EBITDA | $94 | $50 | $110 | $254 |
| *Reconciliation to income (loss) before income taxes* |  |  |  |  |
| Corporate-related costs <sup>(1)</sup> |  |  |  | (21) |
| Restructuring and impairment costs <sup>(2)</sup> |  |  |  | (351) |
| Purchase accounting amortization <sup>(3)</sup> |  |  |  | (12) |
| Restructuring-related activities <sup>(4)</sup> |  |  |  | (5) |
| Depreciation expense |  |  |  | (67) |
| Equity based compensation |  |  |  | (5) |
| Other items <sup>(5)</sup> |  |  |  | (9) |
| Net financing charges |  |  |  | (48) |
| Other pension expense |  |  |  | (1) |
| Income (loss) before income taxes |  |  |  | (265) |

---

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments, including restructuring charges of $18 million and a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities, including $5 million in restructuring-related charges primarily recorded in cost of sales.

(5) Reflects $8 million of third-party consulting costs associated with strategic planning recorded in SG&A and a $1 million non-recurring loss at affiliates recorded in equity income.

**Adient plc \| Form 10-Q \| 29**

------

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Six Months Ended**<br>**March 31, 2025** | **Six Months Ended**<br>**March 31, 2025** | **Six Months Ended**<br>**March 31, 2025** | **Six Months Ended**<br>**March 31, 2025** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Consolidated** |
| Segment net sales | $3310 | $2360 | $1479 | $7149 |
| &nbsp;&nbsp;Eliminations |  |  |  | (43) |
| Consolidated net sales |  |  |  | $7106 |
| Material costs | 2137 | 1467 | 1020 |  |
| Labor and overhead | 898 | 731 | 203 |  |
| Administrative, engineering and allocated costs | 96 | 98 | 67 |  |
| Equity income |  | 8 | 32 |  |
| Adjusted EBITDA | $179 | $72 | $221 | $472 |
| *Reconciliation to income (loss) before income taxes* |  |  |  |  |
| Corporate-related costs <sup>(1)</sup> |  |  |  | (43) |
| Restructuring and impairment costs <sup>(2)</sup> |  |  |  | (374) |
| Purchase accounting amortization <sup>(3)</sup> |  |  |  | (23) |
| Restructuring-related activities <sup>(4)</sup> |  |  |  | (6) |
| Gain on disposal transactions <sup>(5)</sup> |  |  |  | 4 |
| Depreciation expense |  |  |  | (136) |
| Equity based compensation |  |  |  | (10) |
| Other items <sup>(6)</sup> |  |  |  | (7) |
| Net financing charges |  |  |  | (93) |
| Other pension expense |  |  |  | (2) |
| Income (loss) before income taxes |  |  |  | (218) |

---

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments, including restructuring charges of $31 million, a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit, and an impairment charge of $10 million related to Adient's investment in Adient Aerospace. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities, including $11 million in restructuring-related charges primarily recorded in cost of sales, partially offset by a $5 million gain on sale of a restructured facility in Americas recorded in SG&A.

(5) Reflects a $4 million gain on sale of its partially-owned investment in Setex recorded within equity income. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.

(6) Reflects $8 million of third-party consulting costs associated with strategic planning and a $1 million non-recurring loss at affiliates, partially offset by a $2 million gain on a non-recurring contract related settlement recorded in SG&A.

**Adient plc \| Form 10-Q \| 30**

------

**Additional Segment Information**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| | **Reportable Segments** | **Reportable Segments** | **Reportable Segments** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| **(in millions)** | **Americas** | **EMEA** | **Asia** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| Equity income |  | 4 | 10 | (1) | 13 |
| Depreciation | 27 | 27 | 14 |  | 68 |
| Amortization | 2 |  | 10 |  | 12 |
| Capital Expenditures | 35 | 25 | 13 |  | 73 |

---

<sup>(1)</sup> Specific reconciling item for equity income represents $1 million of restructuring charges at affiliates.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended March 31, 2026** | **Six Months Ended March 31, 2026** | **Six Months Ended March 31, 2026** | **Six Months Ended March 31, 2026** | **Six Months Ended March 31, 2026** |
| | **Reportable Segments** | **Reportable Segments** | **Reportable Segments** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| **(in millions)** | **Americas** | **EMEA** | **Asia** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| Total Assets | 2980 | 2044 | 3157 | 851 | 9032 |
| Investment in partially-owned affiliates | 2 | 46 | 253 |  | 301 |
| Equity income |  | 9 | 34 | (3) | 40 |
| Depreciation | 58 | 53 | 26 |  | 137 |
| Amortization | 3 |  | 20 |  | 23 |
| Capital Expenditures | 63 | 49 | 26 |  | 138 |

---

<sup>(1)</sup> Corporate-related assets primarily include cash and assets held for sale. Specific reconciling item for equity income represents $3 million of restructuring charges at affiliates.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| | **Reportable Segments** | **Reportable Segments** | **Reportable Segments** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| Equity income |  | 3 | 16 | (1) | 18 |
| Depreciation | 30 | 26 | 11 |  | 67 |
| Amortization | 3 |  | 9 |  | 12 |
| Capital Expenditures | 15 | 20 | 10 |  | 45 |

---

<sup>(1)</sup> Specific reconciling item for equity income represents $1 million of restructuring charges at an affiliate.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Six Months Ended March 31, 2025** | **Six Months Ended March 31, 2025** | **Six Months Ended March 31, 2025** | **Six Months Ended March 31, 2025** | **Six Months Ended March 31, 2025** |
| | **Reportable Segments** | **Reportable Segments** | **Reportable Segments** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
|<br>**(in millions)** | **Americas** | **EMEA** | **Asia** | **Reconciling Items**<sup>(1)</sup> | **Consolidated** |
| Total Assets | 2812 | 2017 | 2989 | 771 | 8589 |
| Investment in partially-owned affiliates | 3 | 44 | 246 |  | 293 |
| Equity income |  | 8 | 32 | 3 | 43 |
| Depreciation | 61 | 53 | 22 |  | 136 |
| Amortization | 6 |  | 17 |  | 23 |
| Capital Expenditures | 42 | 47 | 20 |  | 109 |

---

<sup>(1)</sup> Corporate-related assets primarily include cash and assets held for sale. Specific reconciling item for equity income represents a $4 million one-time gain on the sale of Adient's partially-owned investment in Setex, partially offset by $1 million of restructuring charges at an affiliate.

**Adient plc \| Form 10-Q \| 31**

------

***Geographic Information***

Revenue by geographic area is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
| **Net Sales**<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| **Americas** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United States | $1731 | $1565 | $3199 | $3010 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mexico | 694 | 606 | 1322 | 1214 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Americas | 79 | 70 | 158 | 145 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regional elimination | (620) | (542) | (1153) | (1059) |
|  | 1884 | 1699 | 3526 | 3310 |
| **EMEA** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Germany | 236 | 242 | 462 | 451 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Poland | 225 | 214 | 431 | 415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Czech Republic | 185 | 180 | 354 | 356 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Spain | 195 | 179 | 393 | 360 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sweden | 160 | 142 | 319 | 281 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Romania | 135 | 123 | 265 | 242 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other EMEA | 448 | 456 | 859 | 847 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regional elimination | (312) | (305) | (606) | (592) |
|  | 1272 | 1231 | 2477 | 2360 |
| **Asia** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;China | 332 | 286 | 757 | 621 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Thailand | 124 | 131 | 241 | 254 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Korea | 119 | 126 | 230 | 273 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Japan | 119 | 106 | 225 | 213 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other Asia | 62 | 74 | 140 | 152 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Regional elimination | (22) | (16) | (40) | (34) |
|  | 734 | 707 | 1553 | 1479 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inter-segment elimination | (25) | (26) | (47) | (43) |
| **Total** | $3865 | $3611 | $7509 | $7106 |

---

**16. Nonconsolidated Partially-Owned Affiliates**

Investments in the net assets of nonconsolidated partially-owned affiliates are reported in the investments in partially-owned affiliates line in the consolidated statements of financial position as of March 31, 2026 and September 30, 2025. Equity in the net income of nonconsolidated partially-owned affiliates are reported in the equity income line in the consolidated statements of income (loss) for the three and six months ended March 31, 2026 and 2025, respectively. Adient maintains total investments in partially-owned affiliates of $301 million and $276 million at March 31, 2026 and September 30, 2025, respectively. Operating

**Adient plc \| Form 10-Q \| 32**

------

information for nonconsolidated partially-owned affiliates is as follows:

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** |
| Income statement data: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net sales | $1664 | $1819 |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | $176 | $159 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | $82 | $80 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income attributable to the entity | $80 | $78 |

---

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for transactions involving Adient's investments in nonconsolidated partially-owned affiliates.

**17. Commitments and Contingencies**

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product recall, product liability, casualty environmental, safety and health, intellectual property, employment, trade compliance, commercial and contractual matters, and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Costs related to such matters were not material to the periods presented.

Adient accrues for potential environmental liabilities when it is probable a liability has been incurred and the amount of the liability is reasonably estimable. Reserves for environmental liabilities totaled $2 million and $3 million at March 31, 2026 and September 30, 2025, respectively. Adient reviews the status of its environmental sites on a quarterly basis and adjusts its reserves accordingly. Such potential liabilities accrued by Adient do not take into consideration possible recoveries of future insurance proceeds. They do, however, take into account the likely share other parties will bear at remediation sites. It is difficult to estimate Adient's ultimate level of liability at many remediation sites due to the large number of other parties that may be involved, the complexity of determining the relative liability among those parties, the uncertainty as to the nature and scope of the investigations and remediation to be conducted, the uncertainty in the application of law and risk assessment, the various choices and costs associated with diverse technologies that may be used in corrective actions at the sites, the often quite lengthy periods over which eventual remediation may occur, and changing environmental laws. Nevertheless, Adient does not currently believe that any claims, penalties or costs in connection with known environmental matters will have a material adverse effect on Adient's financial position, results of operations or cash flows.

**18. Related Party Transactions**

In the ordinary course of business, Adient enters into transactions with related parties, such as equity affiliates. Such transactions consist of the sale or purchase of goods and other arrangements.

The following table sets forth the location and amounts of net sales to and purchases from related parties included in Adient's consolidated statements of income (loss):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | | **2026** | **2025** | **2026** | **2025** |
| Net sales to related parties | Net sales | $22 | $28 | $50 | $84 |
| Purchases from related parties | Cost of sales | 73 | 76 | 164 | 159 |

---

**Adient plc \| Form 10-Q \| 33**

------

The following table sets forth the locations and amount of accounts receivable due from and payable to related parties in Adient's consolidated statements of financial position:

---

| | | | |
|:---|:---|:---|:---|
| **(in millions)** | | **March 31, 2026** | **September 30, 2025** |
| Accounts receivable from related parties | Accounts receivable | $11 | $16 |
| Accounts payable to related parties | Accounts payable/other current liabilities | 27 | 58 |

---

Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for transactions involving Adient's investments in nonconsolidated partially-owned affiliates which have impacted Adient's related party transactions.

**Adient plc \| Form 10-Q \| 34**

------

---

| | |
|:---|:---|
| **Item 2.** | **Management's Discussion and Analysis of Financial Condition and Results of Operations** |

---

***Forward-Looking Statements***

*This section and other parts of this Quarterly Report on Form 10-Q contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as "future," "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "will," "would," "could," "can," "may," "forecast," "project," "should," or similar terms. Forward-looking statements are not guarantees of future performance and Adient's actual results may differ significantly from the results discussed in the forward-looking statements. Adient cautions that these statements are subject to numerous important risks, uncertainties, assumptions and other factors, some of which are beyond Adient's control, that could cause Adient's actual results to differ materially from those expressed or implied by such forward-looking statements, including, among others, risks related to: the effects of local and national economic, credit and capital market conditions (including the persistence of high interest rates, vehicle affordability and volatile currency exchange rates) on the global economy, increased competitive pressures in the EMEA and Asia regions from Chinese OEMs, uncertainties in U.S. administrative policy regarding trade agreements, tariffs and other international trade relations, automotive vehicle production levels, mix and schedules, as well as the concentration of exposure to certain automotive manufacturers particularly new entrants in the China market, shifts in market shares among vehicles, vehicle segments or away from vehicles on which Adient has significant content, changes in consumer demand, risks associated with Adient's joint ventures, volatile energy markets, Adient's ability and timing of customer recoveries for increased input costs, the availability of raw materials and component products (including components required by Adient's customers for the manufacture of vehicles), risks associated with warranty and product recall and product liability exposures, geopolitical uncertainties such as the Middle East and Ukraine conflicts and the impact on the regional and global economies and additional pressure on commodities, supply chain and vehicle production, the ability of Adient to effectively launch new business at forecast and profitable levels, the ability of Adient to successfully identify suitable opportunities for organic investment and/or acquisitions and to integrate such investments and/or acquisitions, work stoppages, including due to strikes, supply chain disruptions and similar events, wage inflationary pressures due to labor shortages and new labor negotiations, the ability of Adient to execute its restructuring plans and achieve the desired benefit, the ability of Adient to meet debt service requirements and terms of future financing, the impact of global tax reform legislation, the impact of more aggressive positions taken by tax authorities, potential adjustment of the value of deferred tax assets, global climate change and related emphasis on sustainability matters by various stakeholders, and the ability of Adient to achieve its sustainability-related goals, cancellation of, or changes to, commercial arrangements, and the ability of Adient to identify, recruit and retain key leadership. Additional information regarding these and other risks related to Adient's business that could cause actual results to differ materially from what is contained in the forward-looking statements is included in the section entitled "Risk Factors," contained in this Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2026 and the Annual Report on Form 10-K for the fiscal year ended September 30, 2025. The following discussion should be read in conjunction with the consolidated financial statements and notes thereto included within this report as well as within Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. All information presented herein is based on Adient's fiscal calendar. Unless otherwise stated, references to particular years, quarters, months or periods refer to Adient's fiscal years ended in September and the associated quarters, months and periods of those fiscal years. The forward-looking statements included in this Form 10-Q are made only as of the date of this report, unless otherwise specified, and Adient assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.*

**Overview**

Adient is a global leader in the automotive seating supply industry and maintains relationships with the largest global automotive original equipment manufacturers, or OEMs. Adient's proprietary technologies extend into virtually every area of automotive seating solutions, including complete seating systems, frames, mechanisms, foam, head restraints, armrests and trim covers. Adient is an independent seat supplier with global scale and the capability to design, develop, engineer, manufacture and deliver complete seat systems and components in every major automotive producing region in the world.

Adient designs, manufactures and markets a full range of seating systems and components for passenger cars, commercial vehicles and light trucks, including vans, pick-up trucks and sport/crossover utility vehicles. Adient operates approximately 200 wholly- and majority-owned manufacturing, assembly or sequencing facilities, with operations in 29 countries. Additionally, Adient has partially-owned affiliates in China, Asia, Europe and North America. Through its global footprint and vertical integration, Adient leverages its capabilities to drive growth in the automotive seating industry.

**Adient plc \| Form 10-Q \| 35**

------

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income (loss) before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring-related costs, net mark-to-market adjustments on pension plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker. Refer to Note 15, "Segment Information," of the notes to the consolidated financial statements for additional information on Adient's reportable segments.

**Factors Affecting Adient's Operating Environment**

The results presented below are not necessarily indicative of full-year results as Adient, along with the automotive industry, continues to face a dynamic environment surrounding future production volume. This dynamic environment is the result of a combination of factors experienced over the recent past including the impact of higher energy, freight and other costs resulting from the conflicts in the Middle East and other parts of the world, softening consumer demand due in part to vehicle affordability, the direct and indirect impacts resulting from the imposition of U.S. and foreign tariffs, market share loss for foreign/luxury OEMs in the Asia reporting unit combined with modest expected margin declines as Adient continues to win new business with local OEMs in China, intensifying competition from Chinese imports and lower exports to China from EMEA as domestic brands expand in China, overcapacity in the EMEA reporting unit resulting in pricing pressure, continued disruptions caused by slower EV adoption rates, and interruptions from other suppliers due to production downtime and shortages of critical components or raw materials. Adient has also been experiencing increased levels of discussions with taxing authorities and more aggressive negotiations by the tax authorities as part of tax audits and related inquiries, resulting in higher levels of uncertainty on tax assessment outcomes. These factors may continue to negatively impact Adient's results in the foreseeable future. Adient is also monitoring developments associated with the Supreme Court decision related to tariffs issued under the International Emergency Economic Powers Act ("IEEPA"). No amounts have been recorded as of March 31, 2026 for recoveries from the government due to various legal, regulatory and administrative uncertainties that remain unresolved. The impact of potential recoveries is not expected to be material to Adient's results of operations and operating cash flows. Refer to the consolidated results of operations and segment analysis discussion below for additional information on the impacts of these items on Adient's results.

**Global Automotive Industry**

Adient conducts its business globally in the automotive industry, which is highly competitive and sensitive to economic, political and social factors in the various regions. During the three and six months ended March 31, 2026, global light vehicle production decreased 0.9% and increased 0.7%, respectively, primarily driven by reduced production volumes in North America and China, partially offset by higher production volumes in Asia.

Light vehicle production levels by geographic region are provided below:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Light Vehicle Production** | **Light Vehicle Production** | **Light Vehicle Production** | **Light Vehicle Production** | **Light Vehicle Production** | **Light Vehicle Production** |
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(units in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Global | 21.5 | (0.9)% | 21.7 | 46.2 | 0.7% | 45.9 |
| North America | 3.7 | (2.6)% | 3.8 | 7.2 | (2.7)% | 7.4 |
| South America | 0.7 | —% | 0.7 | 1.5 | —% | 1.5 |
| EMEA | 4.6 | —% | 4.6 | 9.3 | 2.2% | 9.1 |
| China | 6.5 | (5.8)% | 6.9 | 16.3 | (0.6)% | 16.4 |
| Asia, excluding China, and Other | 6.0 | 5.3% | 5.7 | 11.9 | 3.5% | 11.5 |
| Source: S&P Global, April 2026 | Source: S&P Global, April 2026 |  |  |  |  |  |

---

**Adient plc \| Form 10-Q \| 36**

------

**Financial Results Summary**

Significant aspects of Adient's financial results for the second quarter of fiscal 2026 include the following:

• Adient recorded net sales of $3,865 million for the second quarter of fiscal 2026, representing an increase of $254 million, or 7%, when compared to the second quarter of fiscal 2025. The increase in net sales is primarily attributable to the favorable impact of foreign currencies, higher overall production volumes in Americas and Asia, net of lower overall production volumes in EMEA, and a net favorable impact of commercial pricing adjustments including customer cost recoveries.

**•** Gross profit was $257 million, or 6.6% of net sales, for the second quarter of fiscal 2026 compared to $261 million, or 7.2% of net sales for the second quarter of fiscal 2025. Profitability was lower due primarily to lower production volume/mix and unfavorable operating performance, partially offset by the favorable impact of foreign currencies.

• Equity income was $13 million for the second quarter of fiscal 2026, compared to $18 million for the second quarter of fiscal 2025. The decrease is primarily attributable to unfavorable production volumes and unfavorable operating performance at partially-owned affiliates.

**•** Net income attributable to Adient was $27 million for the second quarter of fiscal 2026, compared to net loss attributable to Adient of $335 million for the second quarter of fiscal 2025. The higher net income in the second quarter of fiscal 2026 is primarily attributable to a $333 million non-cash goodwill impairment charge relating to the EMEA reporting unit in the prior year, the favorable impact of foreign currencies, lower income tax expense, lower SG&A expenses and a decrease in income attributable to noncontrolling interests, partially offset by unfavorable production volume/mix and lower equity income.

**Consolidated Results of Operations**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Net sales | $3865 | 7% | $3611 | $7509 | 6% | $7106 |
| Cost of sales | 3608 | 8% | 3350 | 7035 | 6% | 6629 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 257 | (2)% | 261 | 474 | (1)% | 477 |
| Selling, general and administrative expenses | 138 | (4)% | 144 | 268 | —% | 269 |
| Restructuring and impairment costs | 5 | (99)% | 351 | 29 | (92)% | 374 |
| Equity income | 13 | (28)% | 18 | 40 | (7)% | 43 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings (loss) before interest and income taxes | 127 | >100% | (216) | 217 | >100% | (123) |
| Net financing charges | 48 | —% | 48 | 96 | 3% | 93 |
| Other pension expense | 3 | >100% | 1 | 4 | 100% | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before income taxes | 76 | >100% | (265) | 117 | >100% | (218) |
| Income tax provision | 32 | (33)% | 48 | 74 | 6% | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | 44 | >100% | (313) | 43 | >100% | (288) |
| Income attributable to noncontrolling interests | 17 | (23)% | 22 | 38 | (19)% | 47 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) attributable to Adient | $27 | >100% | $(335) | $5 | >100% | $(335) |

---

**Net Sales**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Net sales | $3865 | 7% | $3611 | $7509 | 6% | $7106 |

---

Net sales increased by $254 million, or 7%, in the second quarter of fiscal 2026 as compared to the second quarter of fiscal 2025 due to the favorable impact of foreign currencies ($157 million), higher production volumes in Americas and Asia, net of

**Adient plc \| Form 10-Q \| 37**

------

lower production volumes in EMEA as a result of softening customer demand and strategic portfolio actions ($85 million) and the net favorable impact of commercial pricing adjustments including customer cost and tariff recoveries ($12 million).

Net sales increased by $403 million, or 6%, during the first six months of fiscal 2026 as compared to the first six months of fiscal 2025 due to the favorable impact of foreign currencies ($255 million), higher production volumes in Americas and Asia, net of lower production volumes in EMEA as a result of softening customer demand and strategic portfolio actions ($126 million) and the net favorable impact of commercial pricing adjustments including customer and tariff cost recoveries ($22 million).

**Cost of Sales / Gross Profit**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2026** | **Change** | **2025** | **2025** | **2026** | **Change** | **2025** |
| Cost of sales | $| 3608 | 8% | $| 3350 | $7035 | 6% | $6629 |
| Gross profit | $| 257 | (2)% | $| 261 | $474 | (1)% | $477 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of sales | 6.6% | 6.6% |  | 7.2% | 7.2% | 6.3% |  | 6.7% |

---

Cost of sales increased by $258 million, or 8%, and gross profit decreased by $4 million, or 2%, in the second quarter of fiscal 2026 as compared to the second quarter of fiscal 2025. The year over year increase in cost of sales was primarily due to the unfavorable impact of foreign currencies ($143 million), the impact of higher production volumes in Americas and Asia, net of lower production volumes in EMEA as a result of softening customer demand and strategic portfolio actions ($103 million) and unfavorable net operating performance including increased program launch costs and the impact of tariffs partially offset by favorable material cost adjustments ($12 million). Gross profit for the three months ended March 31, 2026 was impacted by unfavorable volume/mix and unfavorable net operating performance mainly due to increased program launch costs, partially offset by the favorable impact of foreign currencies.

Cost of sales increased by $406 million, or 6%, and gross profit decreased by $3 million, or 1%, during the first six months of fiscal 2026 as compared to the first six months of fiscal 2025. The year over year increase in cost of sales was primarily due to the unfavorable impact of foreign currencies ($228 million), the impact of higher production volumes in Americas and Asia, partially offset by lower production volumes in EMEA as a result of softening customer demand and strategic portfolio actions ($155 million) and unfavorable net operating performance including increased program launch costs, inefficiencies related to certain customer disruptions and the impact of tariffs partially offset by favorable material cost adjustments ($23 million). Gross profit for the six months ended March 31, 2026 was impacted by unfavorable volume/mix and unfavorable net operating performance including increased program launch costs and the impact of tariffs, partially offset by the favorable impact of foreign currencies and favorable material cost adjustments.

Refer to the segment analysis below for a discussion of segment profitability.

**Selling, General and Administrative (SG&A) Expenses**

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2026** | **Change** | **2025** | **2025** | **2026** | **2026** | **Change** | **2025** | **2025** |
| Selling, general and administrative expenses | $| 138 | (4)% | $| 144 | $| 268 | —% | $| 269 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of sales | 3.6% | 3.6% |  | 4.0% | 4.0% | 3.6% | 3.6% |  | 3.8% | 3.8% |

---

SG&A decreased by $6 million, or 4%, in the second quarter of fiscal 2026 as compared to the second quarter of fiscal 2025 due to lower net engineering and other administrative spending ($13 million), third-party consulting costs associated with strategic planning in the previous year ($8 million), partially offset by higher compensation expense including equity and performance-based incentive compensation costs ($8 million) and the unfavorable impact of foreign currencies ($7 million).

SG&A decreased by $1 million during the first six months of fiscal 2026 as compared to the first six months of fiscal 2025 due to lower net engineering and other administrative spending ($26 million), third-party consulting costs associated with strategic planning in the previous year ($8 million), partially offset by higher compensation expense including equity and performance-

**Adient plc \| Form 10-Q \| 38**

------

based incentive compensation costs ($17 million), the unfavorable impact of foreign currencies ($11 million) and a non-recurring gain on the sale of an asset in the prior year ($5 million).

**Restructuring and Impairment Costs**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Restructuring and impairment costs | $5 | (99)% | $351 | $29 | (92)% | $374 |

---

Restructuring and impairment costs were lower by $346 million during the second quarter of fiscal 2026 and lower by $345 million during the first six months of fiscal 2026 due to a prior-year $333 million impairment charge relating to EMEA's goodwill during the three months ended March 31, 2025 and a $10 million impairment loss recorded on the Adient Aerospace investment during the first six months of fiscal 2025. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for information related to Adient's restructuring plans.

**Equity Income**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Equity income | $13 | (28)% | $18 | $40 | (7)% | $43 |

---

Equity income was $13 million for the second quarter of fiscal 2026, compared to $18 million in the second quarter of fiscal 2025. The decrease is primarily attributable to unfavorable production volumes at partially-owned affiliates ($4 million) and unfavorable operating performance at partially-owned affiliates ($1 million).

Equity income was $40 million during the first six months of fiscal 2026, compared to $43 million during the first six months of fiscal 2025. The decrease is primarily attributable to a one-time gain on the sale of Setex during the first quarter of fiscal 2025 ($4 million) and restructuring-related charges related to certain of Adient's investment in non-consolidated affiliates ($2 million), partially offset by favorable operating performance at partially-owned affiliates ($2 million) and favorable production volumes at partially-owned affiliates ($1 million).

**Net Financing Charges**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Net financing charges | $48 | —% | $48 | $96 | 3% | $93 |

---

Net financing charges in the second quarter of fiscal 2026 were comparable to the second quarter of fiscal 2025, and higher by $3 million during the first six months of fiscal 2026 as compared to the first six months of fiscal 2025. The increase was primarily due to higher interest expense as a result of higher average interest rates. Refer to Note 8, "Debt and Financing Arrangements," of the notes to the consolidated financial statements for further information related to Adient's debt transactions and components of net financing charges.

**Other Pension Expense**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Other pension expense | $3 | >100% | $1 | $4 | 100% | $2 |

---

**Adient plc \| Form 10-Q \| 39**

------

Other pension expense was higher by $2 million in the second quarter of fiscal 2026 as compared to the second quarter of fiscal 2025, and higher by $2 million during the first six months of fiscal 2026 as compared to the first six months of fiscal 2025 due to a curtailment loss of $2 million recorded in the Asia segment. Refer to Note 12, "Retirement Plans," of the notes to the consolidated financial statements for information related to the non-service components of Adient's net periodic pension costs.

**Income Tax Provision**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Income tax provision | $32 | (33)% | $48 | $74 | 6% | $70 |

---

The second quarter fiscal 2026 income tax expense of $32 million was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, partially offset by tax benefits related to statute expirations. The second quarter fiscal 2025 income tax expense of $48 million was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, $19 million of tax expense related to adjustments to net operating loss deferred tax assets, $9 million of tax expense related to the establishment of an uncertain tax position, and the impact of the impairment of the non-tax-deductible portion of the EMEA goodwill balance for which there is no corresponding income tax benefit.

The first six months of fiscal 2026 income tax expense of $74 million was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances and the establishment of uncertain tax positions as a result of initiating a foreign tax audit settlement, partially offset by tax benefits related to audit closures and statute expirations. The first six months of fiscal 2025 income tax expense of $70 million was higher than the Irish statutory rate of 12.5% primarily due to the inability to record a tax benefit for losses in jurisdictions with valuation allowances, $19 million of tax expense related to adjustments to net operating loss deferred tax assets, $9 million of tax expense related to the establishment of an uncertain tax position, and the impact of the impairment of the non-tax-deductible portion of the EMEA goodwill balance for which there is no corresponding income tax benefit, partially offset by $7 million of tax benefits from the release of uncertain tax positions due to statute expirations.

**Income Attributable to Noncontrolling Interests**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Income attributable to noncontrolling interests | $17 | (23)% | $22 | $38 | (19)% | $47 |

---

The decrease in income attributable to noncontrolling interests in the second quarter of fiscal 2026 as compared to the second quarter of fiscal 2025 is primarily attributable to lower production volumes and unfavorable operating performance at certain consolidated joint ventures in Asia.

The decrease in income attributable to noncontrolling interests during the first six months of fiscal 2026 as compared to the first six months of fiscal 2025 is primarily attributable to lower production volumes and unfavorable operating performance at certain consolidated joint ventures in Asia.

**Net Income (Loss) Attributable to Adient**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Net income (loss) attributable to Adient | $27 | >100% | $(335) | $5 | >100% | $(335) |

---

Net income attributable to Adient was $27 million for the second quarter of fiscal 2026, compared to net loss attributable to Adient of $335 million for the second quarter of fiscal 2025. The higher net income in the second quarter of fiscal 2026 is primarily attributable to a $333 million non-cash goodwill impairment charge relating to the EMEA reporting unit in the prior

**Adient plc \| Form 10-Q \| 40**

------

year, the favorable impact of foreign currencies, lower income tax expense, lower SG&A expenses and a decrease in income attributable to noncontrolling interests, partially offset by unfavorable production volume/mix and lower equity income.

Net income attributable to Adient was $5 million during the first six months of fiscal 2026, compared to net loss attributable to Adient of $335 million during the first six months of fiscal 2025. The higher net income during the first six months of fiscal 2026 is primarily attributable to a $333 million non-cash goodwill impairment charge relating to the EMEA reporting unit in the previous year, the favorable impact of foreign currencies and a decrease in income attributable to noncontrolling interests, partially offset by unfavorable production volume/mix and lower equity income.

**Comprehensive Loss Attributable to Adient**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Comprehensive loss attributable to Adient | $(29) | 87% | $(229) | $(37) | 92% | $(454) |

---

Comprehensive loss attributable to Adient was $29 million for the second quarter of fiscal 2026 compared to $229 million of comprehensive loss for the second quarter of fiscal 2025. The lower comprehensive loss attributable to Adient is due primarily to a higher net income in the second quarter of fiscal 2026 compared to a net loss in the second quarter of fiscal 2025 ($357 million) and lower comprehensive income attributable to noncontrolling interests ($13 million), partially offset by the unfavorable impact of foreign currency translation adjustments ($131 million), realized and unrealized losses on derivatives in the second quarter of fiscal 2026 compared to a gains in the second quarter of fiscal 2025 ($39 million).

Comprehensive loss attributable to Adient was $37 million for the first six months of fiscal 2026 compared to $454 million of comprehensive loss for the first six months of fiscal 2025. The lower comprehensive loss attributable to Adient is due primarily to a higher net income in the first six months of fiscal 2026 compared to a net loss in the first six months of fiscal 2025 ($331 million) and lower realized and unrealized losses on derivatives ($119 million), partially offset by the unfavorable impact of foreign currency translation adjustments ($25 million) and higher comprehensive income attributable to noncontrolling interests ($8 million).

**Segment Analysis**

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East, and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items. Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

The results presented below are not necessarily indicative of full-year results as Adient, along with the automotive industry, continues to face a dynamic environment surrounding future production volume. This dynamic environment is the result of a combination of factors experienced over the recent past including the impact of higher energy, freight and other costs resulting from the conflicts in the Middle East and other parts of the world, softening consumer demand due in part to vehicle affordability, the direct and indirect impacts resulting from the imposition of U.S. and foreign tariffs, market share loss for foreign/luxury OEMs in the Asia reporting unit combined with modest expected margin declines as Adient continues to win new business with local OEMs in China, intensifying competition from Chinese imports and lower exports to China from EMEA as domestic brands expand in China, overcapacity in the EMEA reporting unit resulting in pricing pressure along with continued disruptions caused by slower electric vehicle adoption rates, and interruptions from other suppliers due to production downtime and shortages of critical components or raw materials. Adient has also been experiencing increased levels of discussions with taxing authorities and more aggressive negotiations by the tax authorities as part of tax audits and related inquiries, resulting in higher levels of uncertainty on tax assessment outcomes. These factors may continue to negatively impact Adient's results in the foreseeable future. Adient is also monitoring developments associated with the Supreme Court decision related to tariffs issued under the International Emergency Economic Powers Act ("IEEPA"). No amounts have been recorded as of March 31, 2026 for recoveries from the government due to various legal, regulatory and administrative uncertainties that

**Adient plc \| Form 10-Q \| 41**

------

remain unresolved. The impact of potential recoveries is not expected to be material to Adient's results of operations and operating cash flows. Refer to the Factors Affecting Adient's Operating Environment section in this Form 10-Q and within our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, for additional information on factors that have impacted Adient.

Financial information relating to Adient's reportable segments is as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **(in millions)** | **Americas** | **EMEA** | **Asia** | **Corporate/Eliminations** | **Consolidated** |
| *Three months ended March 31, 2026* | *Three months ended March 31, 2026* | *Three months ended March 31, 2026* | *Three months ended March 31, 2026* | *Three months ended March 31, 2026* | *Three months ended March 31, 2026* |
| Net sales | $1884 | $1272 | $734 | $(25) | $3865 |
| Adjusted EBITDA | $109 | $45 | $92 | $(23) | $223 |
| *Six months ended March 31, 2026* | *Six months ended March 31, 2026* | *Six months ended March 31, 2026* | *Six months ended March 31, 2026* | *Six months ended March 31, 2026* | *Six months ended March 31, 2026* |
| Net sales | $3526 | $2477 | $1553 | $(47) | $7509 |
| Adjusted EBITDA | $189 | $79 | $207 | $(45) | $430 |
| *Three months ended March 31, 2025* | *Three months ended March 31, 2025* | *Three months ended March 31, 2025* | *Three months ended March 31, 2025* | *Three months ended March 31, 2025* | *Three months ended March 31, 2025* |
| Net sales | $1699 | $1231 | $707 | $(26) | $3611 |
| Adjusted EBITDA | $94 | $50 | $110 | $(21) | $233 |
| *Six months ended March 31, 2025* | *Six months ended March 31, 2025* | *Six months ended March 31, 2025* | *Six months ended March 31, 2025* | *Six months ended March 31, 2025* | *Six months ended March 31, 2025* |
| Net sales | $3310 | $2360 | $1479 | $(43) | $7106 |
| Adjusted EBITDA | $179 | $72 | $221 | $(43) | $429 |

---

The following is a reconciliation of Adient's reportable segments' adjusted EBITDA to income (loss) before income taxes:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** | **2026** | **2025** |
| Adjusted EBITDA |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Americas | $109 | $94 | $189 | $179 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EMEA | 45 | 50 | 79 | 72 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asia | 92 | 110 | 207 | 221 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 246 | 254 | 475 | 472 |
| Corporate-related costs <sup>(1)</sup> | (23) | (21) | (45) | (43) |
| Restructuring and impairment costs <sup>(2)</sup> | (5) | (351) | (29) | (374) |
| Purchase accounting amortization <sup>(3)</sup> | (12) | (12) | (23) | (23) |
| Restructuring related charges <sup>(4)</sup> | (6) | (5) | (13) | (6) |
| Gain on disposal transactions <sup>(5)</sup> |  |  |  | 4 |
| Depreciation | (68) | (67) | (137) | (136) |
| Equity based compensation | (9) | (5) | (17) | (10) |
| Other items <sup>(6)</sup> | 4 | (9) | 6 | (7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Earnings (loss) before interest and income taxes | 127 | (216) | 217 | (123) |
| Net financing charges | (48) | (48) | (96) | (93) |
| Other pension expense | (3) | (1) | (4) | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income (loss) before income taxes | $76 | $(265) | $117 | $(218) |

---

**Adient plc \| Form 10-Q \| 42**

------

<u>Notes:</u>

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and non-recurring asset impairments. The three and six months ended March 31, 2026 reflects restructuring charges of $5 million and $29 million, respectively. The three months ended March 31, 2025 reflects restructuring charges of $18 million and a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit. The six months ended March 31, 2025 reflects restructuring charges of $31 million, a non-recurring, non-cash goodwill impairment charge of $333 million in the EMEA reporting unit and an impairment charge of $10 million related to Adient's investment in Adient Aerospace. Refer to Note 13, "Restructuring and Impairment Costs" of the notes to the consolidated financial statements for additional information.

(3) Reflects amortization of intangible assets including those related to partially-owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities. The three months ended March 31, 2026 includes $5 million of restructuring-related charges primarily recorded in cost of sales and $1 million of restructuring charges at partially-owned affiliates recorded within equity income. The six months ended March 31, 2026 includes $10 million of restructuring-related charges primarily recorded in cost of sales and $3 million of restructuring charges at partially-owned affiliates recorded within equity income. The three months ended March 31, 2025 includes $5 million in restructuring-related charges primarily recorded in cost of sales. The six months ended March 31, 2025 includes $11 million in restructuring-related charges primarily recorded in cost of sales, partially offset by a $5 million gain on sale of a restructured facility in Americas recorded in SG&A.

(5) The six months ended March 31, 2025 includes a $4 million gain on sale of its partially-owned investment in Setex recorded within equity income. Refer to Note 3, "Acquisitions and Divestitures," of the notes to the consolidated financial statements for additional information.

(6) The three months ended March 31, 2026 includes a $5 million one-time, non-recurring reversal of contingent liabilities with a customer recorded in cost of sales, partially offset by $1 million of transaction costs recorded in SG&A. The six months ended March 31, 2026 includes a $5 million one-time, non-recurring reversal of contingent liabilities with a customer recorded in cost of sales and a $2 million gain on a non-recurring contract related settlement recorded in SG&A, partially offset by $1 million of transaction costs recorded in SG&A. The three months ended March 31, 2025 includes $8 million of third-party consulting costs associated with strategic planning recorded in SG&A and a $1 million non-recurring loss at affiliates recorded in equity income. The six months ended March 31, 2025 includes $8 million of third-party consulting costs associated with strategic planning and a $1 million non-recurring loss at affiliates, partially offset by a $2 million gain on a non-recurring contract related settlement recorded in SG&A.

***Americas***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Net sales | $1884 | 11% | $1699 | $3526 | 7% | $3310 |
| Adjusted EBITDA | $109 | 16% | $94 | $189 | 6% | $179 |

---

Net sales increased during the second quarter of fiscal 2026 by $185 million primarily due to higher production volumes ($131 million), net favorable commercial pricing adjustments including customer cost and tariff recoveries ($48 million) and the favorable impact of foreign currencies ($6 million).

Net sales increased during the first six months of fiscal 2026 by $216 million primarily due to higher production volumes ($130 million), net favorable commercial pricing adjustments including customer cost and tariff recoveries ($77 million) and the favorable impact of foreign currencies ($9 million).

Adjusted EBITDA increased during the second quarter of fiscal 2026 by $15 million due to favorable net operating performance reflecting favorable customer pricing and the net impact of tariffs, partially offset by unfavorable material cost adjustments, higher overhead and program launch costs ($9 million), the favorable impact of foreign currencies ($4 million), lower SG&A and engineering expenses ($1 million) and favorable production volumes/mix ($1 million).

**Adient plc \| Form 10-Q \| 43**

------

Adjusted EBITDA increased during the first six months of fiscal 2026 by $10 million due to lower SG&A and engineering expenses ($11 million), the favorable impact of foreign currencies ($6 million) and favorable net operating performance reflecting favorable customer pricing, partially offset by operating inefficiencies due to production disruption costs related to certain customers, unfavorable material cost, higher program launch costs and the net impact of tariffs ($8 million), partially offset by unfavorable production volumes/mix ($14 million) and lower equity income ($1 million).

***EMEA***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Net sales | $1272 | 3% | $1231 | $2477 | 5% | $2360 |
| Adjusted EBITDA | $45 | (10)% | $50 | $79 | 10% | $72 |

---

Net sales increased during the second quarter of fiscal 2026 by $41 million primarily as a result of the favorable impact of foreign currencies ($134 million), partially offset by lower production volumes as a result of softening customer demand and strategic portfolio actions ($83 million) and an unfavorable impact of net commercial pricing adjustments including customer cost recoveries ($10 million).

Net sales increased during the first six months of fiscal 2026 by $117 million primarily as a result of the favorable impact of foreign currencies ($228 million), partially offset by lower production volumes as a result of softening customer demand and strategic portfolio actions ($97 million) and an unfavorable impact of net commercial pricing adjustments including customer cost recoveries ($14 million).

Adjusted EBITDA decreased during the second quarter of fiscal 2026 by $5 million due to unfavorable production volume/mix ($13 million), partially offset by the favorable impact of foreign currencies ($5 million), lower SG&A and engineering expenses ($2 million) and higher equity income ($1 million).

Adjusted EBITDA increased during the first six months of fiscal 2026 by $7 million due to favorable net operating performance reflecting favorable material cost adjustments and lower overhead and launch costs, partially offset by unfavorable customer pricing ($11 million), the favorable impact of foreign currencies ($4 million) and higher equity income ($1 million), partially offset by unfavorable production volume/mix ($8 million) and higher SG&A and engineering expenses ($1 million).

***Asia***

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **Change** | **2025** | **2026** | **Change** | **2025** |
| Net sales | $734 | 4% | $707 | $1553 | 5% | $1479 |
| Adjusted EBITDA | $92 | (16)% | $110 | $207 | (6)% | $221 |

---

Net sales increased during the second quarter of fiscal 2026 by $27 million due to higher production volumes ($33 million) and the favorable impact of foreign currencies ($19 million), partially offset by net unfavorable commercial pricing adjustments including customer cost recoveries ($25 million).

Net sales increased during the first six months of fiscal 2026 by $74 million due to higher production volumes ($92 million) and the favorable impact of foreign currencies ($22 million), partially offset by net unfavorable commercial pricing adjustments including customer cost recoveries ($40 million).

Adjusted EBITDA decreased during the second quarter of fiscal 2026 by $18 million due to unfavorable net operating performance reflecting unfavorable customer pricing adjustments and higher overhead and product launch costs, partially offset by favorable material costs ($18 million), lower equity income ($7 million) and unfavorable production volumes/mix ($6 million), partially offset by lower SG&A and engineering expenses ($9 million) and the favorable impact of foreign currencies ($4 million).

**Adient plc \| Form 10-Q \| 44**

------

Adjusted EBITDA decreased during the first six months of fiscal 2026 by $14 million due to unfavorable net operating performance reflecting unfavorable customer pricing and higher overhead and product launch costs, partially offset by favorable material cost adjustments ($25 million), unfavorable production volumes/mix ($7 million), partially offset by lower SG&A and engineering expenses ($9 million), the favorable impact of foreign currencies ($7 million) and higher equity income ($2 million).

**Liquidity and Capital Resources**

Adient's primary liquidity needs are to fund general business requirements, including working capital, capital expenditures, restructuring costs, debt service requirements and discretionary spending to repurchase Adient's shares. Adient's principal sources of liquidity are cash flows from operating activities, the revolving credit facility and other debt issuances, and existing cash balances. Adient actively manages its working capital and associated cash requirements and continually seeks more effective uses of cash. Working capital is highly influenced by the timing of cash flows associated with sales and purchases, and therefore can be difficult to manage at times. See below for discussion of Adient's financing arrangements. Adient believes that its current financial resources will be sufficient to fund its liquidity requirements for at least the next twelve months. Fiscal 2026 cash flows are expected to be lower than fiscal 2025 cash flows due primarily to reduced profitability resulting from lower production volumes, higher capital spending to fund growth initiatives, non-recurring tax settlements and an acceleration in the timing of commercial settlements in fiscal 2025. During the second quarter of fiscal 2026, Adient experienced higher operating cash flows resulting from certain commercial and derivative transactions approximating $90 million, which are expected to be settled and paid in the third quarter of fiscal 2026.

***Indebtedness***

As of September 30, 2025, Adient US LLC ("Adient US"), a wholly owned subsidiary of Adient, together with certain of Adient's other subsidiaries, maintained an asset-based revolving credit facility (the "ABL Credit Facility"), which provided for a revolving line of credit up to $1,250 million, including a North American subfacility of up to $950 million and a European subfacility of up to $300 million, subject to borrowing base capacity and certain other restrictions, including a minimum fixed charge coverage ratio. During the first quarter of fiscal 2026, Adient amended the ABL Credit Facility, reducing the maximum facility from $1,250 million to $1,000 million (consisting of a North American subfacility of up to $895 million and a European subfacility of up to $105 million). Under the amended agreement, Adient will pay a commitment fee of 0.20% - 0.25% (previously 0.25% to 0.375%) on the unused portion of the commitments under the asset-based revolving credit facility based on average global availability. Adient incurred $6 million of costs associated with this amendment, which was recorded as deferred financing costs. The amended ABL Credit Facility is set to mature in October 2030 (previously November 2027), subject to certain springing maturity provisions. Letters of credit are limited to the lesser of (x) $150 million and (y) the aggregate unused amount of commitments under the amended ABL Credit Facility then in effect. Subject to certain conditions, the amended ABL Credit Facility may be expanded by up to $500 million in additional commitments. Loans under the amended ABL Credit Facility may be denominated, at the option of Adient, in U.S. Dollars, Euros, Pounds Sterling or Swedish Krona. It also provides flexibility for future amendments to the amended ABL Credit Facility to incorporate certain sustainability-based pricing provisions. The amended ABL Credit Facility is secured on a first-priority lien on all accounts receivable, inventory and bank accounts (and funds on deposit therein) and a second-priority lien on all of the tangible and intangible assets of certain Adient subsidiaries. Interest is payable on the amended ABL Credit Facility at a fluctuating rate of interest determined by reference to Term SOFR, in the case of amounts outstanding in Dollars, EURIBOR, in the case of amounts outstanding in Euros, STIBOR, in the case of amounts outstanding in Swedish Krona and SONIA, in the case of amounts outstanding in Pounds Sterling, in each case, plus an applicable margin of 1.25% - 1.75% (previously 1.50% to 2.00%). During the second quarter of fiscal 2026, Adient drew down and fully repaid an aggregate of $150 million on the amended ABL Credit Facility. No amounts were outstanding as of March 31, 2026 under this facility, and total availability on that date was $957 million (net of $8 million of letters of credit).

In addition, Adient Global Holdings S.à r.l., a wholly-owned subsidiary of Adient, maintains a senior secured term loan facility (the "Term Loan B Agreement"), that had an outstanding balance of $622 million and $626 million as of March 31, 2026 and September 30, 2025, respectively. During the first quarter of fiscal 2025, the Term Loan B Agreement was amended to reduce the applicable margin from 2.75% to 2.25%. Adient incurred $1 million of costs associated with the modification, which was recorded as deferred financing costs. The maturity date was also extended from April 2028 to January 2031. The amended Term Loan B Agreement amortizes in equal quarterly installments at a rate of 1.00% per annum of the original principal amount thereof, with the remaining balance due at final maturity. The amended Term Loan B Agreement permits Adient to incur incremental term loans in an aggregate amount not to exceed the greater of $750 million and an unlimited amount subject to a pro forma first lien secured net leverage ratio of not greater than 1.75 to 1.00 and certain other conditions. Interest on the amended Term Loan B Agreement accrues at Term SOFR plus an applicable margin. During the second quarter of fiscal 2026,

**Adient plc \| Form 10-Q \| 45**

------

Adient further amended the Term Loan B Agreement to reduce the applicable margin from 2.25% to 2.00%. Adient incurred $1 million of costs associated with this amendment, which was recorded as deferred financing costs.

The amended ABL Credit Facility and amended Term Loan B Agreement contain covenants that are usual and customary for facilities and debt instruments of this type and that, among other things, restrict the ability of Adient and its restricted subsidiaries to: create certain liens and enter into sale and lease-back transactions; create, assume, incur or guarantee certain indebtedness; pay dividends or make other distributions on, or repurchase or redeem, Adient's capital stock or certain other debt; make other restricted payments; and consolidate or merge with, or convey, transfer or lease all or substantially all of Adient's and its restricted subsidiaries' assets, to another person. These covenants are subject to a number of other limitations and exceptions set forth in the agreements. The agreements also provide for customary events of default, including, but not limited to, cross-default clauses with other debt arrangements, failure to pay principal and interest, failure to comply with covenants, agreements or conditions, and certain events of bankruptcy or insolvency involving Adient and its significant subsidiaries.

Adient Global Holdings Ltd. ("AGH"), a wholly-owned subsidiary of Adient, maintains (i) $500 million in aggregate principal amount of 7.00% senior secured notes due 2028, (ii) $500 million in aggregate principal amount of 8.250% senior unsecured notes due 2031 and (iii) $795 million in aggregate principal amount of 7.50% senior unsecured notes due 2033. Interest on notes (i) and (ii) are paid on April 15 and October 15 each year. Interest on note (iii) is paid on February 15 and August 15 each year. These notes contain covenants that are usual and customary.

***Sources of Cash Flows***

---

| | | |
|:---|:---|:---|
| | **Six Months Ended<br>March 31,** | **Six Months Ended<br>March 31,** |
|<br>**(in millions)** | **2026** | **2025** |
| Cash provided by operating activities | $161 | $64 |
| Cash used by investing activities | (143) | (78) |
| Cash used by financing activities | (121) | (149) |
| Capital expenditures | (138) | (109) |

---

*Operating Cash Flows:* The increase in cash flows from operating activities is primarily due to higher accounts payable and accrued liabilities and a higher level of cash payments associated with restructuring activities in the previous year, partially offset by higher account receivables and an increase in inventories. During the second quarter of fiscal 2026, Adient experienced higher operating cash flows resulting from certain commercial and derivative transactions approximating $90 million, which are expected to be settled and paid in the third quarter of fiscal 2026.

*Investing Cash Flows:* The increase in cash used by investing activities is primarily attributable to higher capital expenditures and proceeds received from the sale of Adient's interest in Setex during the first six months of fiscal 2025.

*Financing Cash Flows:* The decrease in cash used by financing activities is primarily attributable to the acquisition of the noncontrolling interest in Technotrim during the first six months of fiscal 2025. Refer to Note 11, "Equity and Noncontrolling Interests," of the notes to the consolidated financial statements for additional information.

*Capital expenditures:* Capital expenditures during the first six months of fiscal 2026 were driven by higher levels of investments in artificial intelligence ("AI"), automation and innovation as well as expenditures related to new and replacement programs.

***Working capital***

---

| | | |
|:---|:---|:---|
| **(in millions)** | **March 31, 2026** | **September 30, 2025** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current assets | $4247 | $4133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current liabilities | 3870 | 3687 |
| Working capital | $377 | $446 |

---

Working capital decreased by $69 million primarily due to an increase in accounts payable and a decrease in cash and cash equivalents, partially offset by decreases in accrued compensation and benefits and other noncurrent liabilities, as well as increases in net accounts receivable, inventories and other current assets.

**Adient plc \| Form 10-Q \| 46**

------

***Restructuring Costs***

During the first six months of fiscal 2026, Adient committed to restructuring actions ("2026 Plan") resulting in charges of $28 million. Additional charges totaling $1 million related to prior year plans were also recorded during the six months ended March 31, 2026. The restructuring actions relate to cost reduction initiatives and consist primarily of workforce reductions in EMEA. The 2026 Plan is being implemented in response to manufacturing footprint and structural changes occurring in the global automotive industry and to ensure Adient maintains a competitive cost structure by reducing operating, administrative and engineering costs, and increasing efficiencies. Restructuring actions associated with the 2026 Plan will primarily occur in fiscal years 2026 and 2027 and are expected to be substantially complete by fiscal year 2027. Adient currently estimates that upon completion of the restructuring actions, the 2026 Plan will reduce annual operating costs by approximately $15 million, which is primarily the result of lower costs of sales and SG&A due to reduced employee-related costs; however, minimal impact to net earnings is expected.

Adient's management closely monitors its overall cost structure and continually analyzes each of its businesses for opportunities to consolidate current operations, improve operating efficiencies and locate facilities in low cost countries in close proximity to customers. This ongoing analysis includes a review of its manufacturing, engineering, purchasing and administrative functions, as well as the overall global footprint for all its businesses. Because of the importance of new vehicle sales by major automotive manufacturers to operations, Adient is affected by the general business conditions in the automotive industry. Future adverse developments in the automotive industry could impact Adient's liquidity position, lead to impairment charges and/or require additional restructuring of its operations.

***Repurchases of Equity Securities***

In November 2022, Adient's board of directors authorized the repurchase of Adient's ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient's ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. From fiscal 2023 through fiscal 2025, Adient repurchased and immediately retired a total of 17,297,377 ordinary shares. The aggregate amount of cash paid to repurchase the shares was $465 million, all of which had been spent through September 30, 2025. During the first quarter of fiscal 2026, Adient repurchased and immediately retired 1,232,932 of its ordinary shares at an average purchase price per share of $20.27, for an aggregate amount of cash paid of $25 million. No shares were repurchased during the second quarter of fiscal 2026. As of March 31, 2026, the remaining aggregate amount of authorization remaining under the share repurchase authorization was $110 million.

**Off-Balance Sheet Arrangements** 

Adient enters into supply chain financing programs in certain domestic and foreign jurisdictions to either sell or discount accounts receivable without recourse to third-party institutions. Sales or discounts of accounts receivable are reflected as a reduction of accounts receivable on the consolidated statements of financial position and the proceeds are included in cash flows from operating activities in the consolidated statements of cash flows. As of March 31, 2026, $176 million was funded under these programs compared to $185 million as of September 30, 2025.

Adient also has a program with an external financial institution under which Adient's suppliers can sell their receivables from Adient to the financial institution at their sole discretion. Adient is not a party to the agreements between the participating suppliers and the financial institution. Adient's obligation under the program is to pay the original amounts of supplier invoices to the financial institution on the original invoice dates. No fees are paid and no assets are pledged by Adient. The payment terms for trade payables can range from 45 days to 120 days depending on types of services and goods being purchased. The payment terms for molds, dies and other tools that are acquired as part of pre-production activities are in general longer, and are normally dependent on the terms which Adient has agreed with its customers. As of March 31, 2026, and September 30, 2025, Adient's liabilities related to this program were $107 million and $105 million, respectively. Cash flows related to the program are all presented within operating activities in Adient's consolidated statements of cash flows.

**Adient plc \| Form 10-Q \| 47**

------

**Effects of Inflation and Changing Prices**

The effects of inflation have historically not been significant to Adient's results of operations. Generally, Adient has been able to implement operating efficiencies to sufficiently offset cost increases, which over time have been moderate. The automotive industry has experienced periods of significant volatility in commodity and other input costs, including steel, petrochemical, freight, energy and labor costs. This price volatility may continue into the future as demand increases and/or supply remains constrained. Price volatility has resulted in an overall increase of input costs for Adient that may not be, or may only be partially, offset through customer negotiations.

**Critical Accounting Estimates and Policies**

See "Critical Accounting Estimates and Policies" under the heading "Item 7" of Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025, for a discussion of critical accounting estimates and policies. There have been no material changes to Adient's critical accounting estimates and policies during the three months ended March 31, 2026.

**New Accounting Pronouncements**

See Note 1, "Organization and Summary of Significant Accounting Policies," of the notes to the consolidated financial statements for a discussion of new accounting pronouncements.

**Other Information**

Not applicable

---

| | |
|:---|:---|
| **Item 3.** | **Quantitative and Qualitative Disclosures About Market Risk** |

---

As of March 31, 2026, Adient had not experienced any adverse changes in market risk exposures that materially affected the quantitative and qualitative disclosures presented in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

---

| | |
|:---|:---|
| **Item 4.** | **Controls and Procedures** |

---

**Evaluation of Disclosure Controls and Procedures**

As of March 31, 2026, Adient's principal executive officer and principal financial officer evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the "Exchange Act")), which are designed to provide reasonable assurance that we are able to record, process, summarize and report the information required to be disclosed in our reports under the Exchange Act within the time periods specified in SEC rules and forms. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of March 31, 2026 to provide reasonable assurance that the information required to be disclosed in reports that we file or submit under the Exchange Act is accumulated and communicated to management, and made known to our principal executive officer and principal financial officer, on a timely basis to ensure that it is recorded, processed, summarized and reported within the time period specified in the SEC's rules and forms.

**Changes in Internal Control over Financial Reporting**

During the second quarter of fiscal 2026, Adient continued to implement a new enterprise resource planning ("ERP") system at certain of its entities in China. The implementation of the ERP system is planned to occur in phases over the coming year for all majority owned entities in China. There were no other changes in internal control over financial reporting during the three months ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

**Adient plc \| Form 10-Q \| 48**

------

**PART II - OTHER INFORMATION**

---

| | |
|:---|:---|
| **Item 1.** | **Legal Proceedings** |

---

Adient is involved in various lawsuits, claims and proceedings incident to the operation of its businesses, including those pertaining to product liability, product safety, environmental, safety and health, intellectual property, employment, trade and other regulatory compliance, commercial and contractual matters and various other matters. Although the outcome of any such lawsuit, claim or proceeding cannot be predicted with certainty and some may be disposed of unfavorably to Adient, it is management's opinion that none of these will have a material adverse effect on Adient's financial position, results of operations or cash flows. Adient accrues for potential liabilities in a manner consistent with accounting principles generally accepted in the United States; that is, when it is probable a liability has been incurred and the amount of the liability is reasonably estimable.

Information with respect to this item may be found in Note 17, "Commitments and Contingencies," of the notes to the consolidated financial statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.

Additional information on Adient's commitments and contingencies can be found in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

---

| | |
|:---|:---|
| **Item 1A.** | **Risk Factors** |

---

Adient has updated or supplemented the below risk factor to reflect recent developments, and this risk factor should be read in combination with those previously reported in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025. To the extent applicable, the following risk factor updates supersede the corresponding risk factor previously reported in Adient's Annual Report on Form 10-K for the fiscal year ended September 30, 2025.

***Risks associated with Adient's non-U.S. operations could adversely affect Adient's business, financial condition and results of operations.***

Adient has significant operations in a number of countries outside the U.S., some of which are located in emerging markets. Long-term economic or political uncertainty in some of the regions of the world in which Adient operates, such as Asia, South America and Europe and other emerging markets, could result in the disruption of markets and negatively affect cash flows from Adient's operations to cover its capital needs and debt service requirements.

In addition, as a result of Adient's global presence, a significant portion of its revenues and expenses is denominated in currencies other than the U.S. Dollar. Adient is therefore subject to foreign currency risks and foreign exchange exposure. While Adient employs financial instruments to hedge some of its transactional foreign exchange exposure, these activities do not insulate Adient completely from those exposures. Exchange rates can be volatile and could adversely impact Adient's financial results and the comparability of results from period to period. Adient's use of financial instruments to limit this risk is guided by strict policies and processes and the success of Adient's hedging programs depends primarily on the performance of the business in comparison with Adient's forecasted sales proceeds and costs. If the forecast and other related factors are incorrect, the transactions entered into may have an adverse impact on Adient's financial results. No assurance can be given that judgment in this respect will be correct.

There are other risks that are inherent in Adient's non-U.S. operations, including the potential for changes in socioeconomic conditions, laws and regulations, including sanctions, import, export, direct and indirect taxes, value-added taxes, labor and environmental laws, and monetary and fiscal policies; protectionist measures that may prohibit acquisitions or joint ventures, or impact trade volumes; unsettled political conditions or instability; government-imposed plant or other operational shutdowns; backlash from foreign labor organizations related to Adient's restructuring actions; asset freezes and seizures; corruption; natural and man-made disasters; global health epidemics (such as COVID-19); hazards and losses; armed conflict, territorial disputes or acts of aggression in Asia, South America, Europe or otherwise; violence, civil and labor unrest; and possible terrorist attacks.

The current conflicts in the Middle East and Iran, as well as the ongoing war in Ukraine following Russia's invasion in 2022, have resulted in significant uncertainty and instability in global vehicle production, supply chains and availability of certain

**Adient plc \| Form 10-Q \| 49**

------

commodities and raw materials. Although Adient has no operations in the Middle East or Ukraine and its operation in Russia has since been disposed, certain of its suppliers as well as customers depend on commodities and other material supplies that originate in the Middle East, Ukraine or Russia. The conflicts have led to increases in the cost of commodities and energy have the potential for shortages, especially in Europe and Asia. In response to Russia's invasion in Ukraine, a number of countries, including the United States, the United Kingdom and members of the European Union, have implemented economic sanctions on Russia and certain Russian enterprises including several large banks. If these conflicts continue or expand, it may trigger a series of additional economic or energy market impacts or further sanctions which in turn could further disrupt the global automotive supply chains by limiting supplies of key components or commodities and increasing inflationary pressures. These ongoing conflicts, along with other geopolitical uncertainties, could have broader adverse impacts on macroeconomic factors that impact Adient's business, cash flows, financial condition and results of operations.

---

| | |
|:---|:---|
| **Item 2.** | **Unregistered Sales of Equity Securities and Use of Proceeds** |

---

**(a) Unregistered Sale of Equity Securities**

None.

**(b) Use of Proceeds**

None.

**(c) Repurchase of Equity Securities**

Share repurchase activity during the three months ended March 31, 2026 was as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Periods** | **Total Number of Shares (or Units) Purchased** | **Average Price Paid per Share (or Unit)** | **Total Number of Shares (or Units) Purchased as Part of Publicly Announced Plans or Programs** | **Approximate Dollar Value of Shares (or Units) that may yet be Purchased Under the Plans or Programs**<br>**(in millions)**<sup>(1)</sup> |
| January 1 to January 31, 2026 |  | $— |  | $110 |
| February 1 to February 28, 2026 |  |  |  | 110 |
| March 1 to March 31, 2026 |  |  |  | 110 |
|  |  | $— |  | $110 |

---

(1) In November 2022, Adient's board of directors authorized the repurchase of Adient's ordinary shares up to an aggregate purchase price of $600 million with no expiration date. Under the share repurchase authorization, Adient's ordinary shares may be purchased either through discretionary purchases on the open market, by block trades or privately negotiated transactions. The number of ordinary shares repurchased, if any, and the timing of repurchases will depend on a number of factors, including share price, trading volume and general market conditions, as well as on working capital requirements, general business conditions and other factors. Repurchased shares are retired immediately upon repurchase.

---

| | |
|:---|:---|
| **Item 3.** | **Defaults Upon Senior Securities** |

---

None.

---

| | |
|:---|:---|
| **Item 4.** | **Mine Safety Disclosures** |

---

Not applicable.

**Adient plc \| Form 10-Q \| 50**

------

---

| | |
|:---|:---|
| **Item 5.** | **Other Information** |

---

During the second quarter of fiscal year 2026, none of Adient's directors or executive officers adopted or terminated any "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as those terms are defined in Item 408(a) of Regulation S-K.

**Adient plc \| Form 10-Q \| 51**

------

---

| | |
|:---|:---|
| **Item 6.** | **Exhibits** |

---

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit No.** | **Exhibit Title** |
| 31.1 | <u>[Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](a03312026exhibit311.htm)</u> |
| 31.2 | <u>[Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](a03312026exhibit312.htm)</u> |
| 32.1 | <u>[Certification of Periodic Financial Report by the Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](a03312026exhibit321.htm)</u> |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101) |

---

**Adient plc \| Form 10-Q \| 52**

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | |
|:---|:---|
| Adient plc | Adient plc |
| By: | /s/ Jerome J. Dorlack |
|  | Jerome J. Dorlack |
|  | President and Chief Executive Officer |
| Date: | May 6, 2026 |
| By: | /s/ Mark A. Oswald |
|  | Mark A. Oswald |
|  | Executive Vice President and Chief Financial Officer |
| Date: | May 6, 2026 |

---

**Adient plc \| Form 10-Q \| 53**

## Exhibit 31.1

---

| |
|:---|
| **Exhibit 31.1** |
| **Certification** |

---

I, Jerome J. Dorlack, certify that:

1 I have reviewed this quarterly report on Form 10-Q of Adient plc;

---

| | |
|:---|:---|
| 2 | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |

---

---

| | |
|:---|:---|
| 3 | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report; |

---

---

| | |
|:---|:---|
| 4 | The Registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have: |

---

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

---

| | |
|:---|:---|
| 5 | The Registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions): |

---

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize, and report financial information; and

 (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 6, 2026 |  |  |
|  |  | By: | /s/ Jerome J. Dorlack |
|  |  |  | Jerome J. Dorlack |
|  |  |  | President and Chief Executive Officer |

---

## Exhibit 31.2

---

| |
|:---|
| **Exhibit 31.2** |
| **Certification** |

---

I, Mark A. Oswald, certify that:

1 I have reviewed this quarterly report on Form 10-Q of Adient plc;

---

| | |
|:---|:---|
| 2 | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |

---

---

| | |
|:---|:---|
| 3 | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report; |

---

---

| | |
|:---|:---|
| 4 | The Registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have: |

---

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

---

| | |
|:---|:---|
| 5 | The Registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions): |

---

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize, and report financial information; and

 (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 6, 2026 |  |  |
|  |  | By: | /s/ Mark A. Oswald |
|  |  |  | Mark A. Oswald |
|  |  |  | Executive Vice President and Chief Financial Officer |

---

## Exhibit 32.1

---

| |
|:---|
| **Exhibit 32.1** |
| **CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**  |
| **PURSUANT TO**  |
| **18 U.S.C. SECTION 1350,**  |
| **AS ADOPTED PURSUANT TO**  |
| **SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**  |

---

I, Jerome J. Dorlack, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Adient plc on Form 10-Q for the period ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Adient plc.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 6, 2026 |  |  |
|  |  | By: | /s/ Jerome J. Dorlack |
|  |  |  | Jerome J. Dorlack |
|  |  |  | President and Chief Executive Officer |

---

I, Mark A. Oswald, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Adient plc on Form 10-Q for the period ended March 31, 2026 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Adient plc.

---

| | | | |
|:---|:---|:---|:---|
| Date: | May 6, 2026 |  |  |
|  |  | By: | /s/ Mark A. Oswald |
|  |  |  | Mark A. Oswald |
|  |  |  | Executive Vice President and Chief Financial Officer |

---

A signed original of this written statement required by Section 906 has been provided to Adient plc and will be retained by Adient plc and furnished to the Securities and Exchange Commission or its staff upon request.

<br>